|
Exhibit 2.1
EXECUTION
COPY
AGREEMENT AND PLAN OF
MERGER
among
INVITROGEN
CORPORATION,
ATOM ACQUISITION,
LLC
and
APPLERA
CORPORATION
Dated as of June 11,
2008
TABLE OF
CONTENTS
|
|
|
|
|
|
ARTICLE I
|
|
|
|
THE MERGER
|
|
|
|
|
|
|
Section 1.1
|
|
The
Merger |
|
6 |
|
Section 1.2
|
|
Closing |
|
6 |
|
Section 1.3
|
|
Effective
Time |
|
6 |
|
Section 1.4
|
|
Effects
of the Merger |
|
7 |
|
Section 1.5
|
|
Certificate of Formation and Limited Liability Company
Agreement of the Surviving Company |
|
7 |
|
Section 1.6
|
|
Managers |
|
7 |
|
Section 1.7
|
|
Officers |
|
7 |
|
Section 1.8
|
|
Subsequent Actions |
|
7 |
|
|
|
ARTICLE II
|
|
|
|
CONVERSION OF SHARES; EXCHANGE OF
CERTIFICATES
|
|
|
|
|
|
|
Section 2.1
|
|
Effect on
Stock |
|
8 |
|
Section 2.2
|
|
Company
Election Procedures |
|
11 |
|
Section 2.3
|
|
Exchange
of Certificates |
|
13 |
|
Section 2.4
|
|
Treatment
of Equity Compensation Grants |
|
17 |
|
|
|
ARTICLE III
|
|
|
|
REPRESENTATIONS AND WARRANTIES OF THE
COMPANY
|
|
|
|
|
|
|
Section 3.1
|
|
Qualification, Organization, Etc. |
|
19 |
|
Section 3.2
|
|
Capital
Stock |
|
21 |
|
Section 3.3
|
|
Corporate
Authority Relative to this Agreement; No Violation |
|
23 |
|
Section 3.4
|
|
Reports
and Financial Statements |
|
24 |
|
Section 3.5
|
|
Sarbanes-Oxley Compliance |
|
25 |
|
Section 3.6
|
|
No
Undisclosed Liabilities |
|
26 |
|
Section 3.7
|
|
No
Violation of Law; Permits |
|
26 |
|
Section 3.8
|
|
Environmental Laws and Regulations |
|
27 |
|
Section 3.9
|
|
Employee
Benefit Plans |
|
27 |
|
Section 3.10
|
|
Absence
of Certain Changes or Events |
|
29 |
|
Section 3.11
|
|
Investigations; Litigation |
|
30 |
|
Section 3.12
|
|
Information Supplied |
|
30 |
|
Section 3.13
|
|
Rights
Agreement |
|
30 |
|
Section 3.14
|
|
Lack of
Ownership of Parent Common Stock |
|
30 |
|
Section 3.15
|
|
Tax
Matters |
|
31 |
|
Section 3.16
|
|
Labor
Matters |
|
33 |
|
Section 3.17
|
|
Intellectual Property |
|
34 |
|
Section 3.18
|
|
Information Technology |
|
36 |
|
Section 3.19
|
|
Opinion
of Financial Advisor |
|
36 |
|
|
|
|
|
|
Section 3.20
|
|
Required
Vote of the Company Stockholders |
|
36 |
|
Section 3.21
|
|
Material
Contracts |
|
36 |
|
Section 3.22
|
|
Regulatory Compliance |
|
37 |
|
Section 3.23
|
|
Product
Recalls |
|
37 |
|
Section 3.24
|
|
Affiliate
Transactions |
|
37 |
|
Section 3.25
|
|
Takeover
Provisions |
|
38 |
|
Section 3.26
|
|
Insurance |
|
38 |
|
Section 3.27
|
|
Finders
or Brokers |
|
38 |
|
Section 3.28
|
|
No
Additional Warranties |
|
38 |
|
|
|
ARTICLE IV
|
|
|
|
REPRESENTATIONS AND WARRANTIES OF
PARENT
|
|
|
|
|
|
|
Section 4.1
|
|
Qualification; Organization, Etc. |
|
39 |
|
Section 4.2
|
|
Capital
Stock |
|
40 |
|
Section 4.3
|
|
Corporate
Authority Relative to this Agreement; No Violation |
|
42 |
|
Section 4.4
|
|
Reports
and Financial Statements |
|
43 |
|
Section 4.5
|
|
Sarbanes-Oxley Compliance |
|
43 |
|
Section 4.6
|
|
No
Undisclosed Liabilities |
|
44 |
|
Section 4.7
|
|
No
Violation of Law; Permits |
|
44 |
|
Section 4.8
|
|
Environmental Laws and Regulations |
|
45 |
|
Section 4.9
|
|
Employee
Benefit Plans |
|
45 |
|
Section 4.10
|
|
Absence
of Certain Changes or Events |
|
47 |
|
Section 4.11
|
|
Investigations; Litigation |
|
47 |
|
Section 4.12
|
|
Information Supplied |
|
47 |
|
Section 4.13
|
|
Rights
Agreement |
|
48 |
|
Section 4.14
|
|
Lack of
Ownership of the Company Common Stock |
|
48 |
|
Section 4.15
|
|
Tax
Matters |
|
48 |
|
Section 4.16
|
|
Labor
Matters |
|
50 |
|
Section 4.17
|
|
Intellectual Property |
|
51 |
|
Section 4.18
|
|
Information Technology |
|
52 |
|
Section 4.19
|
|
Required
Vote of Parent Stockholders |
|
53 |
|
Section 4.20
|
|
Parent
Material Contracts |
|
53 |
|
Section 4.21
|
|
Regulatory Compliance |
|
54 |
|
Section 4.22
|
|
Product
Recalls |
|
54 |
|
Section 4.23
|
|
Financing
Commitments |
|
54 |
|
Section 4.24
|
|
Affiliate
Transactions |
|
55 |
|
Section 4.25
|
|
State
Takeover Statutes |
|
55 |
|
Section 4.26
|
|
Insurance |
|
55 |
|
Section 4.27
|
|
Finders
or Brokers |
|
55 |
|
Section 4.28
|
|
No
Additional Warranties |
|
55 |
|
|
|
ARTICLE V
|
|
|
|
COVENANTS AND AGREEMENTS
|
|
|
|
|
|
|
Section 5.1
|
|
Conduct
of Business by the Company or Parent |
|
56 |
|
Section 5.2
|
|
Tax-Free
Reorganization Treatment |
|
67 |
ii
|
|
|
|
|
|
Section 5.3
|
|
Investigation |
|
67 |
|
Section 5.4
|
|
No
Solicitation |
|
68 |
|
Section 5.5
|
|
Preparation of SEC Documents; Stockholders’
Meetings |
|
72 |
|
Section 5.6
|
|
Affiliate
Agreements |
|
75 |
|
Section 5.7
|
|
Employee
Matters |
|
75 |
|
Section 5.8
|
|
Notification of Certain Matters |
|
79 |
|
Section 5.9
|
|
Filings;
Other Action |
|
79 |
|
Section 5.10
|
|
Takeover
Statute |
|
82 |
|
Section 5.11
|
|
Public
Announcements |
|
83 |
|
Section 5.12
|
|
Indemnification and Insurance |
|
83 |
|
Section 5.13
|
|
Accountants’ “Comfort” Letters |
|
84 |
|
Section 5.14
|
|
Section 16 Matters |
|
84 |
|
Section 5.15
|
|
Control
of Operations |
|
84 |
|
Section 5.16
|
|
Financing
Commitments |
|
85 |
|
Section 5.17
|
|
Corporate
Governance |
|
86 |
|
Section 5.18
|
|
Parent
Name Change |
|
86 |
|
Section 5.19
|
|
Consents |
|
87 |
|
|
|
ARTICLE VI
|
|
|
|
CONDITIONS TO THE MERGER
|
|
|
|
|
|
|
Section 6.1
|
|
Conditions to Each Party’s Obligation to Effect the
Merger |
|
87 |
|
Section 6.2
|
|
Conditions to Obligation of the Company to Effect the
Merger |
|
88 |
|
Section 6.3
|
|
Conditions to Obligation of Parent to Effect the
Merger |
|
89 |
|
|
|
ARTICLE VII
|
|
|
|
TERMINATION
|
|
|
|
|
|
|
Section 7.1
|
|
Termination |
|
90 |
|
Section 7.2
|
|
Effect of
Termination |
|
92 |
|
Section 7.3
|
|
Payments |
|
92 |
|
Section 7.4
|
|
Amendment
or Supplement |
|
93 |
|
Section 7.5
|
|
Extension
of Time, Waiver, Etc |
|
94 |
|
|
|
ARTICLE VIII
|
|
|
|
MISCELLANEOUS
|
|
|
|
|
|
|
Section 8.1
|
|
No
Survival of Representations and Warranties |
|
94 |
|
Section 8.2
|
|
Expenses |
|
94 |
|
Section 8.3
|
|
Counterparts; Effectiveness |
|
94 |
|
Section 8.4
|
|
Governing
Law |
|
94 |
|
Section 8.5
|
|
Jurisdiction; Enforcement |
|
95 |
|
Section 8.6
|
|
Waiver of
Jury Trial |
|
95 |
|
Section 8.7
|
|
Notices |
|
95 |
|
Section 8.8
|
|
Assignment; Binding Effect |
|
96 |
|
Section 8.9
|
|
Date For
Any Action |
|
96 |
|
Section 8.10
|
|
Severability |
|
96 |
iii
|
|
|
|
|
|
Section 8.11
|
|
Entire
Agreement; No Third-Party Beneficiaries |
|
97 |
|
Section 8.12
|
|
Headings |
|
97 |
|
Section 8.13
|
|
Interpretation |
|
97 |
|
Section 8.14
|
|
Definitions |
|
98 |
|
|
|
Exhibit A – Form
of the Company Affiliate Agreement
|
|
|
iv
AGREEMENT AND PLAN OF MERGER,
dated as of June 11, 2008 (the “ Agreement
”), among Invitrogen Corporation, a Delaware corporation
(“ Parent ”), Atom Acquisition, LLC, a Delaware
limited liability company and a direct wholly owned Subsidiary of
Parent (“ Merger Sub ”), and Applera
Corporation, a Delaware corporation (the “ Company
”).
W I T N E S S E T H
:
WHEREAS, the respective
Boards of Directors of Parent and the Company, and the Board of
Managers of Merger Sub, have determined that it is advisable and
fair to and in the best interests of Parent, the Company and Merger
Sub, respectively, and the stockholders of Parent and the Company
and the sole member of Merger Sub, respectively, for Parent and the
Company to engage in a business combination in order to advance
their respective long-term strategic business interests;
and
WHEREAS, in furtherance of
the foregoing, at the Effective Time (as defined in
Section 1.3) the parties hereto intend to effect a merger of
the Company with and into Merger Sub (the “ Merger
”), with Merger Sub being the Surviving Company (as defined
in Section 1.1), all in accordance with the General
Corporation Law of the State of Delaware (the “ DGCL
”) and the Delaware Limited Liability Company Act (the
“ DLLCA ”) and upon the terms and subject to the
conditions set forth herein; and
WHEREAS, prior to the
Effective Time, the Company intends to redeem all of the issued and
outstanding shares of the Company’s Celera Group Common Stock
(as defined in Section 3.2(a)) in exchange for shares of
common stock, par value $.01 per share, of Celera Corporation, a
Delaware corporation (“ Celera Corporation ”),
as a result of which the Company’s Celera Group tracking
stock business (the “ Celera Group ”) will be
split off and be owned by the former holders of the Celera Group
Common Stock (the “ Celera Separation ”);
and
WHEREAS, the respective
Boards of Directors of Parent and the Company, and the Board of
Managers of Merger Sub, have approved and declared the Merger
advisable, upon the terms and subject to the conditions set forth
in this Agreement; and
WHEREAS, subject to the
fiduciary duties of the Company’s Board of Directors under
applicable Laws (as defined in Section 3.7(a)) and
Section 5.4(d) of this Agreement, the Board of Directors of
the Company has resolved to recommend to the Company’s
stockholders the approval and adoption of this Agreement and the
approval of the transactions contemplated hereby, including the
Merger, upon the terms and subject to the conditions set forth in
this Agreement; and
WHEREAS, the Board of
Directors of Parent has approved, and resolved to recommend to
Parent’s stockholders the approval of, the issuance of shares
of Parent Common Stock (as defined in Section 4.2(a)) in
connection with the Merger (the “ Stock Issuance
”); and
WHEREAS, immediately
following execution of this Agreement, Parent, as the sole member
of Merger Sub, will act by written consent to approve and adopt
this Agreement and approved the transactions contemplated hereby,
including the Merger, upon the terms and subject to the conditions
set forth in this Agreement; and
5
WHEREAS, Parent, Merger Sub
and the Company wish to make certain representations, warranties,
covenants and agreements in connection with the Merger and to
prescribe certain conditions to the consummation of the Merger as
set forth herein; and
WHEREAS, for United States
federal income Tax purposes, the Merger is intended to qualify as a
reorganization within the meaning of Section 368(a) of the
United States Internal Revenue Code of 1986, as amended (the
“ Code ”), and this Agreement is hereby adopted
as a plan of reorganization for purposes of Section 368 of the
Code; and
WHEREAS, terms used but not
defined herein shall have the respective meanings ascribed to such
terms in Section 8.14, unless otherwise noted.
NOW THEREFORE, in
consideration of the foregoing and the representations, warranties,
covenants and agreements contained herein, and intending to be
legally bound hereby, Parent, Merger Sub and the Company agree as
follows:
ARTICLE I
THE
MERGER
Section 1.1 The
Merger . Upon the terms and subject to the conditions set forth
in this Agreement and in accordance with the DGCL and the DLLCA,
the Company shall be merged with and into Merger Sub at the
Effective Time. Following the Merger, the separate corporate
existence of the Company shall cease, and Merger Sub shall continue
as the surviving company (the “ Surviving Company
”) and shall succeed to and assume all the rights and
obligations of the Company in accordance with the DGCL and the
DLLCA.
Section 1.2
Closing . The closing of the Merger shall take place at
10:00 a.m., local time, on a date to be specified by the parties
(the “ Closing Date ”) which shall be no later
than the second Business Day (as defined in this Section 1.2)
after the satisfaction or waiver (to the extent permitted by this
Agreement and applicable Law) of the conditions set forth in
Article VI (other than those that are to be satisfied by
action at the Closing) at the offices of DLA Piper US LLP, 1251
Avenue of the Americas, New York, New York 10020, unless another
time, date or place is agreed to in writing by Parent and the
Company; provided, however, that if all the conditions set forth in
Article VI of this Agreement (other than those that are to be
satisfied by action at the Closing) shall not have been satisfied
or (to the extent permitted by this Agreement and applicable Law)
waived on such second Business Day, then the Closing shall take
place on the first Business Day on which all such conditions shall
have been satisfied or (to the extent permitted by this Agreement
and applicable Law) waived. As used in this Agreement, the term
“ Business Day ” shall mean any day other than a
Saturday, Sunday or a day on which banks in New York City are
authorized or obligated by Law or executive order to
close.
Section 1.3 Effective
Time . Subject to the provisions of this Agreement, as promptly
as practicable on the Closing Date, the parties shall file with the
Secretary of State of the State of Delaware a certificate of merger
(the “ Certificate of Merger ”) executed and
acknowledged by the parties in accordance with the relevant
provisions of the DGCL and the DLLCA and, as promptly as
practicable on or after the Closing Date, shall make all other
filings or recordings required under the DGCL and the DLLCA.
The
6
Merger shall become effective upon the
filing of the Certificate of Merger with the Secretary of State of
the State of Delaware, or at such later date and time as Parent and
the Company shall agree and shall specify in the Certificate of
Merger (the date and time that the Merger becomes effective being
the “ Effective Time ”).
Section 1.4 Effects
of the Merger . At and after the Effective Time, the Merger
shall have the effects set forth in this Agreement and the
applicable provisions of the DGCL and the DLLCA. Without limiting
the generality of the foregoing, and subject thereto, at the
Effective Time all the property, rights, privileges, powers and
franchises of the Company and Merger Sub shall vest in the
Surviving Company, and all debts, liabilities and duties of the
Company and Merger Sub shall become the debts, liabilities and
duties of the Surviving Company.
Section 1.5
Certificate of Formation and Limited Liability Company Agreement
of the Surviving Company .
(a) Subject to
Section 5.12 of this Agreement, at the Effective Time, the
certificate of formation of Merger Sub, as in effect immediately
prior to the Effective Time, shall be the certificate of formation
of the Surviving Company until thereafter changed or amended as
provided by the DLLCA or therein, except that as of the Effective
Time, Paragraph 1 of the certificate of formation of the
Surviving Company shall be amended to reflect the name of the
Company (or a variation thereof) as the name of the Surviving
Company.
(b) Subject to
Section 5.12 of this Agreement, at the Effective Time, the
limited liability company agreement of Merger Sub, as in effect
immediately prior to the Effective Time, shall become the limited
liability company agreement of the Surviving Company, until
thereafter changed or amended as provided by the DLLCA, the
certificate of formation of the Surviving Company and such limited
liability company agreement.
Section 1.6
Managers . The managers of Merger Sub immediately prior to
the Effective Time shall, from and after the Effective Time, be the
managers of the Surviving Company, until the earlier of their
death, resignation or removal or until their respective successors
are duly elected and qualified, as the case may be.
Section 1.7
Officers . The officers of the Company immediately prior to
the Effective Time, from and after the Effective Time, shall be the
officers of the Surviving Company, until the earlier of their
death, resignation or removal or until their respective successors
are duly elected and qualified, as the case may be.
Section 1.8
Subsequent Actions . If, at any time after the Effective
Time, the Surviving Company shall consider or be advised that any
deeds, bills of sale, assignments, assurances or any other actions
or things are necessary or desirable to vest, perfect or confirm of
record or otherwise in the Surviving Company its right, title or
interest in, to or under any of the rights, properties or assets of
either of the Company or Merger Sub acquired or to be acquired by
the Surviving Company as a result of, or in connection with, the
Merger or otherwise to carry out this Agreement, the officers and
directors of the Surviving Company shall be authorized
to
7
execute and deliver, in the name and on
behalf of either the Company or Merger Sub, all such deeds, bills
of sale, assignments and assurances and to take and do, in the name
and on behalf of each of such corporations or otherwise, all such
other actions and things as may be necessary or desirable to vest,
perfect or confirm any and all right, title and interest in, to and
under such rights, properties or assets in the Surviving Company or
otherwise to carry out this Agreement.
ARTICLE II
CONVERSION OF SHARES;
EXCHANGE OF CERTIFICATES
Section 2.1 Effect on
Stock . At the Effective Time, by virtue of the Merger and
without any action on the part of the Company, Merger Sub or the
holders of any securities of the Company or Merger Sub:
(a) Conversion of Company
Common Stock . Subject to Sections 2.1(d), 2.1(e) and 2.3,
each issued and outstanding share (other than shares to be
cancelled in accordance with Section 2.1(b) and any Dissenting
Shares (as defined, and to the extent provided in,
Section 2.1(e)) of Applera Corporation – Applied
Biosystems Group Common Stock, par value $.01 per share (“
Company Common Stock ” or “ Shares
”), which prior to the Effective Time and by virtue of the
Celera Separation will be the only class of common stock of the
Company then outstanding, shall thereupon be converted into and
shall thereafter represent the right to receive the following
consideration (the “ Merger Consideration
”):
(i) Each share of Company
Common Stock with respect to which an election to receive a
combination of stock and cash (a “ Mixed Election
”) has been effectively made and not revoked or lost pursuant
to Section 2.2 (each, a “ Mixed Consideration
Electing Share ”) and each Non-Electing Company Share (as
that term is defined in Section 2.2(c) of this Agreement)
shall be converted into the right to receive the combination (which
combination shall hereinafter be referred to as the “
Mixed Consideration ”) of (x) $17.10 in cash (the
“ Per Share Cash Amount ”) and (y) 0.4543
of a share of validly issued, fully paid and non-assessable shares
of Parent Common Stock (the “ Mixed Election Stock
Exchange Ratio ”), subject to adjustment in accordance
with Section 2.1(d) of this Agreement.
(ii) Each share of Company
Common Stock with respect to which an election to receive cash (a
“ Cash Election ”) has been effectively made and
not revoked or lost pursuant to Section 2.2 (each, a “
Cash Electing Company Share ”) shall be converted (
provided that the Available Cash Election Amount (as
defined below) equals or exceeds the Cash Election Amount (as
defined below)) into the right to receive $38.00 in cash without
interest (the “ Per Share Cash Election Consideration
”); except that if (A) the product of the number
of Cash Electing Company Shares and the Per Share Cash Election
Consideration (such product being the “ Cash Election
Amount ”) exceeds (B) the difference between
(x) the product of the Per Share Cash Amount and the total
number of shares of Company Common Stock (other than the Cancelled
Shares, as such term
8
is defined in
Section 2.1(b) of this Agreement) issued and outstanding
immediately prior to the Effective Time minus (y) the product
of the number of Mixed Consideration Electing Shares (including any
Non-Electing Company Shares) and the Per Share Cash Amount (such
difference being the “ Available Cash Election Amount
”), then each Cash Electing Company Share shall be converted
into a right to receive (1) an amount of cash (without
interest) equal to the product of (p) the Per Share Cash
Election Consideration and (q) a fraction, the numerator of
which shall be the Available Cash Election Amount and the
denominator of which shall be the Cash Election Amount (such
fraction being the “ Cash Fraction ”) and
(2) a number of validly issued, fully paid and non-assessable
shares of Parent Common Stock equal to the product of (r) the
Exchange Ratio and (s) one (1) minus the Cash
Fraction.
(iii) Each share of Company
Common Stock with respect to which an election to receive stock
consideration (a “ Stock Election ”) is properly
made and not revoked or lost pursuant to Section 2.2 (each, a
“ Stock Electing Company Share ”) shall be
converted ( provided that the Cash Election Amount
equals or exceeds the Available Cash Election Amount), into the
right to receive 0.8261 shares of validly issued, fully paid and
non-assessable shares of Parent Common Stock (the “
Exchange Ratio ”), subject to adjustment in accordance
with Section 2.1(d) (together with any cash in lieu of
fractional shares of Parent Common Stock to be paid pursuant to
Section 2.4(e), the “ Stock Consideration
”), except that if the Available Cash Election Amount
exceeds the Cash Election Amount, then each Stock Electing Company
Share shall be converted into the right to receive (1) an
amount of cash (without interest) equal to the amount of such
excess divided by the number of Stock Electing Company Shares and
(2) a number of validly issued, fully paid and non-assessable
shares of Parent Common stock equal to the product of (x) the
Exchange Ratio and (y) a fraction, the numerator of which
shall be the Per Share Cash Election Consideration minus the amount
calculated in clause (1) of this paragraph and the denominator
of which shall be the Per Share Cash Election
Consideration.
(iv) If the Twenty-Day VWAP
is less than $46.00 per share of Parent Common Stock, the holder of
each share of Company Common Stock which is converted pursuant to
Section 2.1 into a right to receive any portion of the Merger
Consideration in the form of shares of Parent Common Stock shall,
in addition, receive an amount in cash without interest equal to
the product of (x) the portion of a share of Parent Common
Stock which such holder has a right to receive multiplied by
(y) the lesser of (A) $46.00 minus the Twenty-Day
VWAP and (B) $2.31.
(v) As used in this
Agreement, the following terms shall have the following
meanings:
“ Twenty-Day
VWAP ” means the arithmetic average of the Weighted
Average Price of the Parent Common Stock on each trading day during
the twenty (20) consecutive trading days immediately preceding
the third (3rd) Business Day prior to the Effective
Time.
9
“ Principal
Market ” means the Nasdaq National Market, or if the
Common Stock is not traded on the Nasdaq National Market, then the
principal securities exchange or trading market for the Common
Stock.
“ Weighted Average
Price ” means, for any security as of any date, the
dollar volume-weighted average price for such security on the
Principal Market during the period beginning at 9:30 a.m., New York
City Time, and ending at 4:00 p.m., New York City Time, as reported
by Bloomberg Financial Markets, or any successor thereto (“
Bloomberg ”), through its “Volume at
Price” functions or, if the foregoing does not apply, the
dollar volume-weighted average price of such security in the
over-the-counter market on the electronic bulletin board for such
security during the period beginning at 9:30 a.m., New York City
time, and ending at 4:00 p.m., New York City Time, as reported by
Bloomberg. If the Weighted Average Price cannot be calculated for
such security on such date on any of the foregoing bases, the
Weighted Average Price of such security on such date shall be the
fair market value as mutually agreed upon by Parent and the
Company. All such determinations to be appropriately adjusted for
any stock dividend, stock split or other similar transaction during
such period.
(b) Company, Parent and
Merger Sub-Owned Shares . Each share of Company Common Stock
that is issued and held by the Company or any of the
Company’s direct or indirect wholly owned Subsidiaries, and
each share of Company Common Stock that is owned by Parent or
Merger Sub immediately prior to the Effective Time (collectively,
the “ Cancelled Shares ”) shall automatically be
cancelled and retired and shall cease to exist, and no
consideration shall be issued or delivered in exchange
therefor.
(c) Conversion of Merger
Sub Interests . Each issued and outstanding limited liability
company interest of Merger Sub shall be converted into one validly
issued limited liability company interest of the Surviving
Company.
(d) Adjustments . If
at any time during the period between the date of this Agreement
and the Effective Time, any change in the outstanding shares of
capital stock of Parent or the Company shall occur as a result of
any reclassification, recapitalization, stock split (including a
reverse stock split) or combination, exchange or readjustment of
shares, or any stock dividend or stock distribution with a record
date during such period, the Merger Consideration and the Exchange
Ratio and any other similarly dependent items, as the case may be,
shall be equitably adjusted; provided, however, that nothing
contained in this Section 2.1(d) shall be deemed to permit any
action that Parent or the Company is otherwise prohibited from
taking pursuant to this Agreement or to effect any such adjustment
as a result of the Celera Separation.
(e) Dissenting Shares
. Notwithstanding anything in this Agreement to the contrary,
shares (“ Dissenting Shares ”) of Company Common
Stock issued and outstanding immediately prior to the Effective
Time that are held by any holder who is entitled to demand and
properly demands appraisal of such Dissenting Shares pursuant to,
and who complies in all respects with, the
10
provisions of Section 262 of the
DGCL (“ Section 262 ”)
shall not be converted into the right to receive the Merger
Consideration as provided in Section 2.1(a) of this Agreement,
but instead such holder shall be entitled to payment of the fair
value of such Dissenting Shares in accordance with the provisions
of Section 262. At the Effective Time, all Dissenting Shares
shall no longer be outstanding, shall automatically be canceled and
retired and shall cease to exist, and each holder of Dissenting
Shares shall cease to have any rights with respect thereto, except
the right to receive the fair value of such Dissenting Shares in
accordance with the provisions of Section 262. Notwithstanding
the foregoing, if any such holder shall fail to perfect or
otherwise shall waive, withdraw or lose the right to appraisal
under Section 262, or a court of competent jurisdiction shall
determine that such holder is not entitled to the relief provided
by Section 262, then the right of such holder to be paid the
fair value of such holder’s Dissenting Shares under
Section 262 shall cease and such Dissenting Shares shall be
deemed to be Mixed Consideration Electing Shares that have been
converted at the Effective Time into, and shall have become, the
right to receive the Mixed Consideration as provided in
Section 2.1(a)(i) of this Agreement. The Company shall serve
prompt written notice (but in any event within 48 hours) to Parent
of any demands for appraisal of any shares of Company Common Stock
and any withdrawals of such demands, and Parent shall have the
right to participate in and direct all negotiations and proceedings
with respect to such demands. Prior to the Effective Time, the
Company shall not, without the prior written consent of Parent
(which consent shall not be unreasonably conditioned, withheld or
delayed), voluntarily make any payment with respect to, or settle
or offer to settle, any such demands, or agree to do any of the
foregoing.
Section 2.2 Company
Election Procedures .
(a) Not less than ten
(10) Business Days prior to the mailing of the Joint Proxy
Statement (as defined in Section 3.12), Parent shall designate
a bank or trust company to act as exchange agent hereunder (the
“ Exchange Agent ”), which Exchange Agent shall
be reasonably acceptable to the Company, for the purpose of
exchanging certificates that immediately prior to the Effective
Time represented shares of Company Common Stock (the “
Certificates ”) and shares of Company Common Stock
represented by book-entry (“ Company Book-Entry Shares
”).
(b) Each person who, on or
prior to the Election Date (as defined below), is a record holder
of shares of Company Common Stock other than Dissenting Shares
shall be entitled to specify the number of such holder’s
shares of Company Common Stock with respect to which such holder
makes a Cash Election, a Stock Election or a Mixed
Election.
(c) Parent shall prepare and
file as an exhibit to the Form S-4 (as defined in
Section 3.12) a form of election (the “ Form of
Election ”) in form and substance reasonably acceptable
to the Company. The Form of Election shall specify that delivery
shall be effected, and risk of loss and title to any Certificates
shall pass only upon proper delivery of the Form of Election and
any Certificates. The Company shall mail the Form of Election with
the Joint Proxy Statement to all persons who are record holders of
shares of Company Common Stock as of the record date for the
Company Stockholders’ Meeting (as defined in
Section 5.5(b)). The Form of Election shall be used by each
record holder of shares of Company Common Stock (or, in the case of
nominee record
11
holders, the beneficial owner through
proper instructions and documentation) to make a Cash Election, a
Stock Election or a Mixed Election. In the event that a holder
fails to make a Cash Election, a Stock Election or a Mixed Election
with respect to any shares of Company Common Stock held or
beneficially owned by such holder, then such holder shall be deemed
to have made a Mixed Election with respect to those shares (each
such share, a “ Non-Electing Company Share ”).
The Company shall use its commercially reasonable efforts to make
the Form of Election available to all persons who become record
holders of shares of Company Common Stock during the period between
the record date for the Company Stockholders’ Meeting and the
Election Date.
(d) Any holder’s
election shall have been properly made only if the Exchange Agent
shall have received at its designated office, by 5:00 p.m., New
York City time, on (1) the date of the Company
Stockholders’ Meeting or (2) if the Closing Date is more
than four Business Days following the Company Stockholders’
Meeting, two (2) Business Days preceding the Closing Date (the
“ Election Date ”), a Form of Election properly
completed and signed and accompanied by (i) Certificates
representing the shares of Company Common Stock to which such Form
of Election relates, duly endorsed in blank or otherwise in form
acceptable for transfer on the books of the Company (or by an
appropriate guarantee of delivery of such Certificates as set forth
in such Form of Election from a firm that is an “eligible
guarantor institution” (as defined in Rule 17Ad-15 under the
Securities Exchange Act of 1934, as amended (the “
Exchange Act ”)); provided that such
Certificates are in fact delivered to the Exchange Agent by the
time set forth in such guarantee of delivery) or (ii) in the
case of Company Book-Entry Shares, any additional documents
required by the procedures set forth in the Form of Election. After
a Cash Election, a Stock Election or a Mixed Election is validly
made with respect to any shares of Company Common Stock, no further
registration of transfers of such shares shall be made on the stock
transfer books of the Company, unless and until such Cash Election,
Stock Election or Mixed Election is properly revoked.
(e) Parent and the Company
shall publicly announce the anticipated Election Date at least five
Business Days prior to the anticipated Closing Date. If the Closing
Date is delayed to a subsequent date, the Election Date shall be
similarly delayed to a subsequent date, and Parent and the Company
shall promptly announce any such delay and, when determined, the
rescheduled Election Date.
(f) Any Cash Election, Stock
Election or Mixed Election may be revoked with respect to all or a
portion of the shares of Company Common Stock subject thereto by
the holder who submitted the applicable Form of Election by written
notice received by the Exchange Agent prior to 5:00 p.m., New York
City time, on the Election Date. In addition, all Cash Elections,
Stock Elections and Mixed Elections shall automatically be revoked
if this Agreement is terminated in accordance with Article VII
of this Agreement. If a Cash Election or Stock Election is revoked,
the shares as to which such election previously applied shall be
treated as Mixed Consideration Electing Shares in accordance with
Section 2.1(a)(i) unless a contrary election is submitted by
the holder within the period during which elections are permitted
to be made pursuant to Section 2.2(d). Certificates will not
be returned to holders, and the accounts of holders of Company
Book-Entry Shares will not be credited at the Depository Trust
Company, unless the holder so requests.
12
(g) The determination of the
Exchange Agent (or the joint determination of Parent and the
Company, in the event that the Exchange Agent declines to make any
such determination) shall be conclusive and binding as to whether
or not Cash Elections and Stock Elections shall have been properly
made or revoked pursuant to this Section 2.2 and as to when
Cash Elections, Stock Elections and revocations were received by
the Exchange Agent. The Exchange Agent (or Parent and the Company
jointly, in the event that the Exchange Agent declines to make the
following computation) shall also make all computations
contemplated by Section 2.1(a), and absent manifest error this
computation shall be conclusive and binding. The Exchange Agent
may, with the written agreement of Parent (subject to the consent
of the Company, which shall not be unreasonably withheld, delayed
or conditioned), make any rules as are consistent with this
Section 2.2 for the implementation of the Cash Elections,
Stock Elections provided for in this Agreement as shall be
necessary or desirable to effect these Cash Elections and Stock
Elections.
Section 2.3 Exchange
of Certificates .
(a) Deposit of Merger
Consideration . At or prior to the Effective Time, Parent shall
deposit with the Exchange Agent, for the benefit of the equity
holders of the Company entitled to receive the Merger Consideration
pursuant to this Agreement, (i) certificates or, at
Parent’s option, evidence of shares in book-entry form,
representing shares of Parent Common Stock (the “ Parent
Certificates ”) in denominations as the Exchange Agent
may reasonably specify and (ii) cash, in each case, as is
issuable or payable, respectively, pursuant to this Article II
in respect of shares of Company Common Stock for which Certificates
or Company Book-Entry Shares have been properly delivered to the
Exchange Agent or the cash to be paid in lieu of fractional shares.
Such Parent Certificates (or evidence of book-entry form, as the
case may be) and such cash so deposited, together with any
dividends or distributions with respect thereto, are hereinafter
referred to as the “ Exchange Fund ”.
(b) Exchange
Procedures . As soon as reasonably practicable after the
Effective Time and in any event not later than the second
(2nd) Business Day following the Effective Time, the Exchange
Agent shall mail to each holder of record of a Certificate or
Company Book-Entry Shares whose shares were converted into the
Merger Consideration, pursuant to Section 2.1(a), (i) a
letter of transmittal (which shall specify that delivery shall be
effected, and risk of loss and title to the Certificates, if
applicable, shall pass, only upon delivery of the Certificates to
the Exchange Agent and shall be in such form and have such other
provisions as Parent and the Company may reasonably specify), and
(ii) instructions for use in effecting the surrender of the
Certificates or Company Book-Entry Shares in exchange for the
Merger Consideration. (x) Each former stockholder of the
Company who properly made and did not revoke a Cash Election, Stock
Election or Mixed Election shall be entitled to receive in exchange
for such stockholder’s Cash Electing Company Shares, Stock
Electing Company Shares or Mixed Consideration Electing Shares, as
the case may be; and (y) each holder of Non-Electing Company
Shares, upon surrender to the Exchange Agent of a Certificate or
Company Book-Entry Shares, as applicable, representing such
Non-Electing Company Shares together with a letter of transmittal,
duly completed and validly executed in accordance with the
instructions thereto, and such other documents as may customarily
be required by the Exchange Agent, shall be able to exchange
therefor, the following:
(i) the number of whole
shares of Parent Common Stock, if any, into which such
holder’s shares of Company Common Stock represented by such
holder’s properly surrendered Certificates or Company
Book-Entry Shares, as applicable, were converted in accordance with
this Article II (after taking into account all shares of
Company Common Stock to which an election or non-election were
made), and such Certificates or Company Book-Entry Shares so
surrendered shall be forthwith cancelled, and
13
(ii) a check in an amount of
U.S. dollars (after giving effect to any required withholdings
pursuant to this Section 2.3(b)) equal to (I) the amount
of cash (including the Per Share Cash Election Consideration and
cash in lieu of fractional interests in shares of Parent Common
Stock to be paid pursuant to Section 2.3(e)), if any, into
which such holder’s shares of Company Common Stock
represented by such holder’s properly surrendered
Certificates or Company Book-Entry Shares, as applicable, were
converted in accordance with this Article II, plus
(II) any cash dividends or other distributions that such
holder has the right to receive pursuant to Section 2.3(c). In
the event of a transfer of ownership of Company Common Stock which
is not registered in the transfer records of the Company, a Parent
Certificate representing the proper number of shares of Parent
Common Stock may be issued to a person other than the person in
whose name the Certificate or Company Book-Entry Shares so
surrendered are registered if such Certificate (if applicable)
shall be properly endorsed or otherwise be in proper form for
transfer and the person requesting such issuance shall pay any
transfer or other non-income Taxes (as defined in
Section 3.15(l)) required by reason of the issuance of shares
of Parent Common Stock to a person other than the registered holder
of such Certificate or Company Book-Entry Shares or establish to
the reasonable satisfaction of Parent that any such Tax has been
paid or is not applicable. Parent or the Exchange Agent shall be
entitled to deduct and withhold from the consideration otherwise
payable under this Agreement to any holder of Company Common Stock
such amounts as Parent or the Exchange Agent are required to
withhold or deduct under the Code or any provision of state, local
or foreign Tax Law with respect to the making of such payment. To
the extent that amounts are so withheld by Parent or the Exchange
Agent, such withheld amounts shall be treated for all purposes of
this Agreement as having been paid to the holder of the Company
Common Stock in respect of whom such deduction and withholding were
made by Parent or the Exchange Agent. Until surrendered as
contemplated by this Section 2.3, each Certificate or Company
Book-Entry Share shall be deemed at any time after the Effective
Time to represent only the right to receive upon such surrender the
applicable Merger Consideration as contemplated by this
Article II and cash, if any, in lieu of any fractional share
in accordance with Section 2.3(e). No interest will be paid or
will accrue on any cash payable to holders of Certificates or
Company Book-Entry Shares under the provisions of this
Article II.
(c) Distributions with
Respect to Unexchanged Shares . No dividends or other
distributions with respect to Parent Common Stock with a record
date on or after the Effective Time, or that are payable to the
holders of record thereof who become
14
such on or after the Effective Time,
shall be paid to the holder of any unsurrendered Certificate or
Company Book-Entry Share until such Certificate or Company
Book-Entry Shares are surrendered as provided in this
Article II. All such dividends, other distributions and cash
in lieu of fractional shares of Parent Common Stock which are to be
paid in respect of the shares of Parent Common Stock to be received
upon surrender of the Certificate or Company Book-Entry Shares
shall be paid by Parent to the Exchange Agent and shall be included
in the Exchange Fund, in each case until the surrender of such
Certificate or Company Book-Entry Shares in accordance with this
Article II. Subject to the effect of applicable escheat or
similar Laws and Laws with respect to the withholding of Taxes,
following surrender of any such Certificate or Company Book-Entry
Shares there shall be paid to the holder of the Parent Certificate
representing whole shares of Parent Common Stock issued in exchange
therefor, without interest, (i) at the time of such surrender,
the amount of dividends or other distributions with a record date
after the Effective Time previously paid with respect to such whole
shares of Parent Common Stock and the amount of any cash payable in
lieu of a fractional share of Parent Common Stock to which such
holder is entitled pursuant to Section 2.3(e) and (ii) at
the appropriate payment date, the amount of dividends or other
distributions with a record date after the Effective Time but prior
to such surrender and with a payment date subsequent to such
surrender payable with respect to such whole shares of Parent
Common Stock. Parent shall make available to the Exchange Agent
sufficient cash for the purpose of satisfying its obligations under
clause (i) above.
(d) No Further Ownership
Rights in Company Common Stock . The transfer of shares of
Parent Common Stock issued upon the surrender for the applicable
Merger Consideration in accordance with the terms of this
Article II (including distributions and dividends paid
pursuant to Section 2.3(c) and any cash paid in lieu of
fractional shares pursuant to Section 2.3(e)) shall be deemed
payment in full satisfaction of all rights pertaining to the shares
of Company Common Stock previously represented by such Certificates
or Company Book-Entry Shares, subject , however , to
the Surviving Company’s obligation to pay any dividends or
make any other distributions with a record date prior to the
Effective Time which may have been authorized or made by the
Company on such shares of Company Common Stock which remain unpaid
at the Effective Time, and there shall be no further registration
of transfers on the transfer books of the Surviving Company of the
shares of Company Common Stock which were outstanding immediately
prior to the Effective Time. If, after the Effective Time,
Certificates or Company Book-Entry Shares are presented to the
Surviving Company or the Exchange Agent for any reason, they shall
be cancelled and exchanged as provided in this Article II,
except as otherwise provided by Law.
(e) No Fractional
Shares .
(i) No Parent Certificates or
scrip representing fractional shares of Parent Common Stock shall
be issued upon the surrender for exchange of Certificates or
Company Book-Entry Shares, no dividend or distribution of Parent
shall relate to such fractional share interests, and such
fractional share interests will not entitle the owner thereof to
vote or to any rights of a stockholder of Parent.
15
(ii) As promptly as
practicable following the Effective Time, the Surviving Company
shall pay to the Exchange Agent, for the benefit of each holder of
Company Common Stock, an amount in cash, if any, equal to the
product obtained by multiplying (A) the fractional share
interest to which such holder (after taking into account all shares
of Company Common Stock held at the Effective Time by such holder)
would otherwise be entitled by (B) the closing price for a
share of Parent Common Stock as reported on the Nasdaq Global
Select Market (as reported in The Wall Street Journal , or,
if not reported thereby, any other authoritative source) on the day
of the Effective Time. To the extent that the Exchange Agent shall
sell shares of Parent Common Stock included in the Exchange Fund in
order to satisfy Parent’s obligation to pay cash in lieu of
fractional shares, Parent shall pay any commissions, transfer Taxes
and other out-of-pocket transaction costs in connection with such
sale, if any.
(f) Termination of
Exchange Fund . Any portion of the Exchange Fund which remains
undistributed to the holders of the Certificates or Company
Book-Entry Shares for one year after the Effective Time shall be
delivered to Parent upon demand, and any holders of the
Certificates or Company Book-Entry Shares who have not theretofore
complied with this Article II shall thereafter look only to
Parent for payment of their claim for Merger Consideration, any
cash in lieu of fractional shares of Parent Common Stock and any
dividends or distributions with respect to Parent Common
Stock.
(g) Closing of Transfer
Books . At the Effective Time, the stock transfer books of the
Company shall be closed, and there shall be no further registration
of transfers on the transfer books of the Surviving Company of the
Company Common Stock which were outstanding immediately prior to
the Effective Time. If, after the Effective Time, Certificates or
Company Book-Entry Shares are presented to the Surviving Company or
the Exchange Agent for any reason, they shall be cancelled and
exchanged as provided in this Section 2.3, except as otherwise
provided by Section 2.1(e).
(h) No Liability .
None of the Company, Parent, Merger Sub, the Surviving Company or
the Exchange Agent shall be liable to any person in respect of any
shares of Parent Common Stock (or dividends or distributions with
respect thereto) or cash from the Exchange Fund, in each case,
delivered to a public official pursuant to any applicable abandoned
property, escheat or similar Law. If any Certificate or Company
Book-Entry Shares shall not have been surrendered prior to such
date on which any Merger Consideration, any cash payable to the
holder of such Certificate or Company Book-Entry Shares pursuant to
this Article II or any dividends or distributions payable to
the holder of such Certificate or Company Book-Entry Shares would
otherwise escheat to or become the property of any Governmental
Entity, any such Merger Consideration or cash, dividends or
distributions in respect of such Certificate or Company Book-Entry
Shares shall, to the extent permitted by applicable Law, become the
property of the Surviving Company, and any holders of the
Certificates or Company Book-Entry Shares who have not theretofore
complied with this Article II shall thereafter look only to
Parent for payment of their claim for Merger Consideration, any
cash in lieu of fractional shares of Parent Common Stock and any
dividends or distributions with respect to Parent Common
Stock.
16
(i) Investment of Exchange
Fund . The Exchange Agent shall invest all cash included in the
Exchange Fund, as directed by Parent. Any interest and other income
resulting from such investments shall be paid to Parent.
(j) Lost Certificates
. In the case of any Certificate that has been lost, stolen or
destroyed, upon the making of an affidavit of that fact by the
person claiming such Certificate to be lost, stolen or destroyed
and, if required by the Exchange Agent, the posting by such person
of a bond in customary amount as indemnity against any claim that
may be made against it with respect to such Certificate, the
Exchange Agent will issue in exchange for such lost, stolen or
destroyed Certificate the Merger Consideration and, if applicable,
any cash in lieu of fractional shares, and unpaid dividends and
distributions on shares of Parent Common Stock deliverable in
accordance with this Article II in respect thereof.
Section 2.4 Treatment
of Equity Compensation Grants .
(a) Stock Options . At
the Effective Time, each outstanding unexpired and unexercised
option to purchase or acquire a share of Company Common Stock under
the Company Equity Plans (each, a “ Company Stock
Option ”) shall vest and become fully exercisable,
whether or not then vested or subject to any performance condition
that has not been satisfied. At the Effective Time, each Company
Stock Option shall be converted into an option to purchase the
number of shares of Parent Common Stock equal to the product of
(x) the Stock Option Conversion Fraction (as defined in this
Section 2.4(a)) multiplied by (y) the number of shares of
Company Common Stock which could have been obtained prior to the
Effective Time upon the exercise of each such Company Stock Option
(rounded down to the nearest whole share), at an exercise price per
share (rounded up to the nearest cent) equal to the exercise price
for each such share of Company Common Stock subject to a Company
Stock Option divided by the Stock Option Conversion Fraction, and
all references to the Company in each such option shall be deemed
to refer to Parent, where appropriate. The other terms of such
Company Stock Options shall continue to apply in accordance with
their terms, including pursuant to such preexisting terms and
conditions, provided , however , that Parent shall
treat each Company Stock Option as fully vested and exercisable.
Each Company Stock Option converted pursuant to the terms of this
Section 2.4(a) shall be referred to as a “ Parent
Exchange Option .” In connection with the issuance of
Parent Exchange Options, Parent shall reserve for issuance the
number of shares of Parent Common Stock that will become subject to
Parent Exchange Options pursuant to this Section 2.4(a). As
promptly as reasonably practicable after the Effective Time, Parent
shall issue to each holder of an outstanding Parent Exchange Option
a document evidencing the foregoing assumption by Parent. Parent
shall file a registration statement on Form S-8 (or any successor
or other appropriate form that Parent is eligible to use) under the
Securities Act on the Closing Date with respect to the shares of
Parent Common Stock subject to Parent Exchange Options and shall
use its commercially reasonable efforts to cause such registration
statement to remain effective until the exercise or expiration of
the Parent Exchange Options. For purposes of this
Section 2.4(a), the “ Stock Option Conversion
Fraction ” shall mean the Exchange Ratio subject to
adjustment in accordance with Section 2.1(d).
The number of shares subject
to any Parent Exchange Option and the exercise price per share of
such Parent Exchange Option shall be determined in a manner which
would not result in the conversion of Company Stock Options into
Parent Exchange Options being treated as a new grant of stock
options under Section 409A of the Code, and the Company and
Parent shall agree upon any adjustments to this Section 2.4(a)
necessary to avoid such new grant of stock options.
17
(b) Employee Stock
Purchase Plans . The Company shall take all actions necessary,
subject to applicable Law, pursuant to the terms of the Applera
Corporation 1999 Employee Stock Purchase Plan, as amended, and any
other applicable employee stock purchase plan (collectively,
including sub-plans adopted under such plan for the benefit of
employees outside the U.S, the “ ESPPs ”) in
order to (i) ensure that no offering periods under the ESPPs
commence after the date hereof, (ii) if necessary, shorten the
offering period under the ESPPs in effect at the Effective Time
(the “ Current Offering ”), such that the
Current Offering shall terminate immediately prior to the Effective
Time, (iii) if (ii) above is necessary, permit
participants in the ESPPs to exercise, effective as of immediately
prior to the Effective Time, any purchase rights existing
immediately prior to the Effective Time under the ESPPs to acquire
shares of Company Common Stock at the purchase price set forth in
the ESPPs, and (iv) refund to participants in the ESPPs the
funds that remain in the participants’ accounts after any
such purchase. The Company shall take any and all actions (but
subject to compliance with the terms and conditions of awards and
applicable Law in jurisdictions outside the United States) as may
be necessary to terminate the ESPPs as of the Effective
Time.
(c) Restricted Stock .
As of the Effective Time, each outstanding share of Company Common
Stock granted under the Company 1999 Plan or otherwise that is
subject to restrictions (each, a share of “ Restricted
Stock ”) which have not lapsed immediately prior to the
Effective Time shall become fully vested and treated as Mixed
Consideration Electing Shares pursuant to
Section 2.1(a)(i).
(d) Restricted Stock
Units . As of the Effective Time, each outstanding right to
receive Company Common Stock pursuant to a stock unit award granted
under any Company Equity Plan that is subject to restrictions
(each, a “ Restricted Stock Unit Award ”) which
have not lapsed immediately prior to the Effective Time shall
become fully vested. As of the Effective Time, each such Restricted
Stock Unit Award shall be settled in shares of Company Common Stock
in accordance with the terms of such Restricted Stock Unit Award,
all of which Shares shall be treated as Mixed Consideration
Electing Shares pursuant to Section 2.1(a)(i).
(e) Stock Units .
Immediately prior to the Effective Time, each outstanding right to
receive shares of Company Common Stock pursuant to a stock unit
award or deferred stock award under any Company Equity Plan or the
Applera Corporation Director Stock Purchase and Deferred
Compensation Plan (each, a “ Stock Unit Award
”) that is held by a director who will not become a director
of Parent as of the Effective Time pursuant to Section 5.17
shall be fully vested and settled in shares of Company Common
Stock, but treated in any case in accordance with the terms of such
Stock Unit Award and such director’s election form. All such
shares of Company Common Stock issued pursuant to the immediately
preceding sentence shall be treated as Stock Electing Company
Shares pursuant to Section 2.1(a)(iii). As of the Effective
Time, each outstanding Stock Unit Award that is held by a director
who will become a director of Parent as of the Effective Time
pursuant to Section 5.17 shall be assumed by Parent.
Subject
18
to, and in accordance with, the terms of
the applicable Company Equity Plan or the Applera Corporation
Director Stock Purchase and Deferred Compensation Plan and any
applicable award certificate or other agreement, each Stock Unit
Award referenced in the immediately preceding sentence shall be
converted into the right to receive the number of shares of Parent
Common Stock (or an amount in respect thereof for cash-settled
Stock Unit Awards) equal to the number of shares of Company Common
Stock subject to the Stock Unit Award, multiplied by the Exchange
Ratio, subject to adjustment in accordance with Section 2.1(d)
(rounded down to the nearest whole number of shares of Parent
Common Stock). Each such Stock Unit Award shall have the same terms
and conditions as were in effect immediately prior to the Effective
Time.
ARTICLE III
REPRESENTATIONS AND
WARRANTIES OF THE COMPANY
Except as disclosed in the
Company SEC Documents (excluding any disclosures set forth in any
section of a filed Company SEC Document entitled “Risk
Factors” or “Forward-Looking Statements” or any
other disclosures included in such filings to the extent that they
are forward-looking in nature) or in the corresponding section of
the Disclosure Schedule delivered by the Company to Parent
immediately prior to the execution of this Agreement (the “
Company Disclosure Schedule ”) (it being agreed that
(x) disclosure of any item in any section of the Company
Disclosure Schedule shall be deemed disclosure with respect to
any other section of this Agreement to which the relevance of such
item is reasonably apparent from the face of such disclosure,
(y) no reference to or disclosure of any item or other matter
in the Company Disclosure Schedule shall be construed as an
admission or indication that (1) such item or other matter is
material, (2) such item or other matter is required to be
referred to or disclosed in the Company Disclosure Schedule or
(3) any breach or violation of applicable Laws or any
contract, agreement, arrangement or understanding to which the
Company is a party exists or has actually occurred and
(z) with the exception of the representation regarding
capitalization set forth in Section 3.2 of this Agreement, all
references in this Article III to the “ Company
” or its “ Subsidiaries ” shall be deemed
to be references to the Company and its Subsidiaries after giving
effect to the consummation of the Celera Separation substantially
in accordance with the terms of the Separation Agreement, dated as
of May 8, 2008, by and between the Company and Celera
Corporation (the “ Separation Agreement ”)), the
Company represents and warrants to Parent and Merger Sub as
follows:
Section 3.1
Qualification, Organization, Etc .
(a) The Company is a
corporation duly organized, validly existing and in good standing
under the Laws of the State of Delaware and has the corporate power
and authority to own its properties and assets and to carry on its
business as it is now being conducted. The Company is duly
qualified or licensed to do business and is in good standing in
each jurisdiction in which the ownership of its properties or the
conduct of its business requires such qualification, except for
jurisdictions in which the failure to be so qualified or in good
standing has not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect (as
defined in this Section 3.1) on the Company. As used in this
Agreement, the term “ Material Adverse
19
Effect ” on or with respect
to the Company or Parent, as the case may be, means any effect,
change, fact, event, occurrence, development or circumstance (any
such item, an “ Effect ”) that (A) is or
would reasonably be expected to result in a material adverse effect
on or change in the financial condition, properties, business,
results of operations, or net assets of the Company and all of its
Subsidiaries, taken as a whole, or Parent and all of its
Subsidiaries, taken as a whole, or (B) would reasonably be
expected to result in criminal sanctions or prohibit or materially
restrict or impede the consummation of the transactions
contemplated by this Agreement, including the Merger;
provided , however , that none of the following shall
constitute, or be taken into account in determining whether there
has been, or will be, a “Material Adverse Effect” on or
with respect to the Company or the Parent, as the case may be: any
Effect caused by or resulting from (i) general changes or
developments in the industry in which the Company and its
Subsidiaries or Parent and its Subsidiaries operate, as applicable,
(ii) political instability, acts of terrorism or war,
(iii) any change affecting the United States economy generally
or the economy of any region in which such party or any of its
Subsidiaries conducts business that is material to the business of
such party and its Subsidiaries, (iv) any change in the
Company’s stock price or trading volume or Parent’s
stock price or trading volume (it being understood that the facts
or occurrences giving rise to or contributing to such change in
stock price or trading volume may be deemed to constitute, or be
taken into account in determining whether there has been, or will
be, a Material Adverse Effect), (v) any failure, in and of
itself, by the Company or Parent to meet any internal or published
projections, forecasts or revenue or earnings predictions for any
period ending on or after the date of this Agreement (it being
understood that the facts or occurrences giving rise to or
contributing to such failure may be deemed to constitute, or be
taken into account in determining whether there has been, or will
be, a Material Adverse Effect), (vi) the announcement of the
execution of this Agreement, or the pendency of the consummation of
the Merger, including any termination of, reduction in or similar
negative impact on relationships, contractual or otherwise, with
any customers, suppliers, distributors, partners or employees of
the Company and its Subsidiaries or Parent and its Subsidiaries, as
applicable, to the extent due to the announcement and performance
of this Agreement or the identity of Parent, in the case of the
Company, or the identity of the Company, in the case of Parent, or
the performance of this Agreement and the transactions contemplated
hereby, including compliance with the covenants set forth herein,
(vii) any change in any applicable Law, rule or regulation or
GAAP (as defined in Section 3.4(b)) or interpretation thereof
after the date hereof, (viii) the execution and performance of
or compliance with this Agreement, including any action taken with
the consent of the other party, or (ix) any claim, action,
suit or proceeding alleging breach of fiduciary duty or other
violation of applicable Law relating to this Agreement or the
transactions contemplated by this Agreement, unless, in the case of
clause (i), (ii), (iii) or (vii) above, such Effect
has had or would reasonably be expected to have a materially
disproportionate adverse impact on the financial condition,
properties, business, results of operations net assets of the
Company and its Subsidiaries, taken as a whole, or of Parent and
its Subsidiaries, taken as a whole, relative to other affected
persons. For purposes of the proviso to the immediately preceding
sentence, if an Effect has a materially disproportionate adverse
impact on the financial condition, properties, business, results of
operations or net assets of the Company and its Subsidiaries, taken
as a whole, or of Parent and its Subsidiaries, taken as a whole,
relative to other affected persons, then for purposes of
determining whether a Material Adverse Effect has occurred,
(i) only the extent to which such Effect has
disproportionately affected such party shall be taken into account
and (ii) the determination of whether a Material Adverse
Effect has occurred shall be based on (x) the incremental
impact of such Effect on such party relative to
20
other persons and (y) whether such
incremental impact itself constitutes a Material Adverse Effect.
The copies of the Company’s certificate of incorporation and
by-laws which have been delivered to Parent are complete and
correct copies thereof, each as amended through the date hereof.
The Company is not in violation of any provision of its certificate
of incorporation or by-laws.
(b) Section 3.1(b) of
the Company Disclosure Schedule sets forth a list of each
Subsidiary of the Company that, as of the date of this Agreement
and after giving effect to the Celera Separation, are significant
subsidiaries (as defined in Rule 1-02 of Regulation S-X of the U.S.
Securities and Exchange Commission (the “ SEC
”)) (the “ Company Significant Subsidiaries
”). Except as set forth in Section 3.1(b) of the Company
Disclosure Schedule, all the outstanding shares of capital stock
of, or other equity interests in, each Company Significant
Subsidiary have been validly issued and are fully paid and
nonassessable and are owned directly or indirectly by the Company,
free and clear of all mortgages, pledges, claims, restrictions,
infringements, liens, charges, encumbrances and security interests
and claims of any kind or nature whatsoever (collectively, “
Liens ”) and free of any other restriction (including
preemptive rights and any restriction on the right to vote, sell or
otherwise dispose of such capital stock or other ownership
interests). Each of the Company’s Significant Subsidiaries is
a corporation, partnership or other entity duly organized, validly
existing and, if applicable, in good standing under the laws of its
jurisdiction of incorporation or organization, has the power and
authority to own its properties and to carry on its business as it
is now being conducted, and is duly qualified or licensed to do
business and, if applicable, is in good standing in each
jurisdiction in which the ownership of its property or the conduct
of its business requires such qualification, except for
jurisdictions in which the failure to be so qualified or in good
standing has not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on the
Company.
Section 3.2 Capital
Stock .
(a) As of May 30, 2008,
the authorized capital stock of the Company consists of
1,000,000,000 shares of Company Common Stock, 225,000,000 shares of
Applera Corporation—Celera Group Common Stock, par value
$0.01 per share (“ Celera Group Common Stock ”),
and 10,000,000 shares of preferred stock, par value $.01 per share
(“ Company Preferred Stock ”). As of
May 30, 2008, (i) 168,890,728 shares of Company Common
Stock were issued and outstanding, (ii) 80,000,544 shares of
Celera Group Common Stock were issued and outstanding, and
(iii) no shares of Company Preferred Stock were issued or
outstanding. As of May 30, 2008, the following numbers of
shares of Company Common Stock and Celera Group Common Stock were
subject to outstanding grants under the Company Equity Plans (as
defined in this Section 3.2(a)): (1) 20,549,303.52 shares
of Company Common Stock were issuable upon the exercise or
settlement of (A) Company Stock Options outstanding under The
Perkin-Elmer Corporation 1996 Stock Incentive Plan, The
Perkin-Elmer Corporation 1997 Stock Incentive Plan and The
Perkin-Elmer Corporation 1998 Stock Incentive Plan (collectively,
the “ Company Inactive Equity Plans ”) and under
the Company’s Applied Biosystems Group Amended and Restated
1999 Stock Incentive Plan (the “ Company 1999 Plan
” and, together with the Company Inactive Equity Plans, the
“ Company Equity Plans ”), (B) Restricted
Stock Unit Awards outstanding under the Company 1999 Plan and
(C) Stock Unit
21
Awards outstanding under the Company
Equity Plans and the Applera Corporation 1993 Director Stock
Purchase and Deferred Compensation Plan; (2) 7,641,983.10
shares of Celera Group Common Stock were issuable upon the exercise
or settlement of (A) options under the Company Inactive Equity
Plans and under the Company’s Celera Group Amended and
Restated 1999 Stock Incentive Plan (the “ Celera 1999
Plan ”), (B) restricted stock unit awards
outstanding under the Celera 1999 Plan and (C) stock unit
awards outstanding under the Company Inactive Plans, the Celera
1999 Plan and the Applera Corporation 1993 Director Stock Purchase
and Deferred Compensation Plan; and (3) 15,478 shares of
Celera Group Common Stock were issuable upon the exercise of
options outstanding under the Axys Pharmaceuticals, Inc. 1997
Equity Incentive Plan, the Axys Pharmaceuticals, Inc. 1997
Non-Officer Equity Incentive Plan, and the Axys Pharmaceuticals,
Inc. 1989 Stock Plan. As of May 30, 2008, (x) 28,757,307
shares of Company Common Stock were reserved for issuance under the
Company 1999 Plan; (y) 11,579,792 shares of Celera Group
Common Stock were reserved for issuance pursuant to the Celera 1999
Plan; and (z) 50,000 shares of Company Preferred Stock were
designated as Series A Preferred Stock, par value $0.01 per share,
and 30,000 shares of Company Preferred Stock were designated as
Series B Preferred Stock, par value $0.01 per share, and both the
Series A Preferred Stock and the Series B Preferred Stock were
reserved for issuance upon the exercise of preferred share purchase
rights (the “ Company Rights ”) issued pursuant
to the Rights Agreement, dated April 28, 1999, and amended
April 17, 2002, between the Company and EquiServe Trust
Company, N.A., as successor in interest to Fleet National Bank,
N.A. (f/k/a BankBoston, N.A.), as rights agent (the “
Company Rights Agreement ”). All of the outstanding
shares of Company Common Stock and Celera Group Common Stock are,
and all shares of Company Common Stock and shares of Celera Group
Common Stock reserved for issuance as noted in clauses (1)-(3), and
(x)-(y) above, shall be, when issued in accordance with the
respective terms thereof, duly authorized, validly issued and are
fully paid and non-assessable and free of pre-emptive rights. Upon
the completion of the Celera Separation, (i) all Celera Group
Common Stock will be redeemed and (ii) holders of options,
restricted stock unit awards, and stock unit awards described in
clause (2) above will become holders of such options,
restricted stock unit awards, and stock unit awards that are
exercisable for, or that are convertible or issue into, common
stock of Celera Corporation and will no longer be holders of Celera
Group or Company options, restricted stock unit awards, or stock
unit awards, and no such holders shall have any right to receive
any payment from the Company or pursuant to this Agreement or
otherwise with respect thereto.
(b) Except as set forth in
subsection (a) above, as of the date hereof: (i) the
Company does not have any shares of its capital stock issued or
outstanding other than shares of Company Common Stock or Celera
Group Common Stock that were issued after May 30, 2008, but
were reserved for issuance as set forth in subsection
(a) above, shares of Company Common Stock, Celera Group Common
Stock, and stock unit awards representing rights to receive such
classes of stock that were issued to directors in connection with
their June 2008 compensation payment, and shares of Company
Common Stock and Celera Group Common Stock that were issued (or are
issuable) pursuant to the ESPPs, and (ii) other than rights to
purchase shares of Company Common Stock and Celera Group Common
Stock pursuant to the ESPPs, there are no outstanding
subscriptions, options, warrants, calls, convertible securities or
other similar rights, agreements or commitments relating to the
issuance of capital stock to which the Company or any of the
Company’s Subsidiaries is a party obligating the Company or
any of the Company’s Subsidiaries to (A) issue, transfer
or sell any
22
shares of capital stock or other equity
interests of the Company or any Subsidiary of the Company or
securities convertible into or exchangeable for such shares or
equity interests; (B) grant, extend or enter into any such
subscription, option, warrant, call, convertible securities or
other similar right, agreement, arrangement or commitment to
repurchase; (C) redeem or otherwise acquire any such shares of
capital stock or other equity interests; or (D) provide a
material amount of funds to, or make any material investment (in
the form of a loan, capital contribution or otherwise) in, any
Subsidiary.
(c) Section 3.2(c) of
the Company Disclosure Schedule sets forth a true, complete
and correct list, as of May 30, 2008, of the aggregate number
of (i) shares of Company Common Stock subject to options to
acquire shares of such Company Common Stock, (ii) shares of
Restricted Stock, (iii) shares of Company Common Stock subject
to Restricted Stock Unit Awards; and (iv) Stock Unit Awards,
in each case, outstanding under the Company Equity Plans or under
any other equity incentive plan of the Company and its Subsidiaries
(other than any such awards relating to the Celera Group Common
Stock and excluding rights under the ESPPs).
(d) Neither the Company nor
any of its Subsidiaries (excluding the Celera Group) has
outstanding bonds, debentures, notes or other obligations, the
holders of which have the right to vote (or which are convertible
into or exercisable for securities having the right to vote) with
the shareholders of the Company or such Subsidiary on any
matter.
(e) There are no voting
trusts or other agreements or understandings to which the Company
or any of its Subsidiaries (excluding the Celera Group) is a party
with respect to the voting of the capital stock or other equity
interest of the Company or any of its Subsidiaries (excluding the
Celera Group).
(f) Neither the Company nor
any Subsidiary of the Company (excluding the Celera Group) owns,
directly or indirectly, any amount of capital stock or other equity
investment or debt security in any corporation, partnership,
limited liability company, joint venture, business, trust or other
entity other than interests in another Subsidiary which is material
to the Company (excluding the Celera Group).
Section 3.3 Corporate
Authority Relative to this Agreement; No Violation .
(a) The Company has requisite
corporate power and authority to enter into this Agreement and,
subject to receipt of the Company Stockholder Approval (as defined
in Section 3.20 of this Agreement), to consummate the
transactions contemplated hereby, including the Merger. The
execution and delivery of this Agreement and the consummation of
the transactions contemplated hereby have been duly and validly
authorized by the Board of Directors of the Company and, except for
the (i) Company Stockholder Approval and (ii) the filing
of the Certificate of Merger with the Secretary of State of the
State of Delaware, no other corporate proceedings on the part of
the Company are necessary to authorize the consummation of the
transactions contemplated hereby. The Board of Directors of the
Company has determined (x) that the transactions contemplated
by this Agreement are fair to and in the best interest of the
Company and its stockholders and (y) to recommend that such
stockholders vote in favor of the approval and adoption of this
Agreement and the Merger. This Agreement has been duly and validly
executed and delivered by the Company and, assuming
23
this Agreement constitutes a valid and
binding agreement of the other parties hereto, constitutes a valid
and binding agreement of the Company, enforceable against the
Company in accordance with its terms (except to the extent that
enforceability may be limited by applicable bankruptcy, insolvency,
reorganization or other Laws affecting the enforcement of
creditors’ rights generally or by principles governing the
availability of equitable remedies).
(b) Other than in connection
with or in compliance with (i) the provisions of the DGCL and
the DLLCA, (ii) the Securities Act of 1933, as amended (the
“ Securities Act ”), (iii) the Exchange
Act, (iv) the Hart-Scott-Rodino Antitrust Improvements Act of
1976, as amended (the “ HSR Act ”), (v) any
applicable non-United States competition, antitrust and investment
laws, including any required notifications and filings under
Council Regulation (EC) 139/2004 of the European Community, as
amended (the “ ECMR ”), (vi) the approvals
set forth on Section 3.3(b) of the Company Disclosure
Schedule, and (vii) the rules and regulations of the New York
Stock Exchange (the “ NYSE ”) (the consents and
approvals referenced in clauses (i) through (vii) above
being collectively referred to herein as the “ Company
Approvals ”), no authorization, consent or approval of,
or filing with, any United States or foreign governmental or
regulatory agency, commission, court, body, entity or authority
(each, a “ Governmental Entity ”) is necessary
for the consummation by the Company of the transactions
contemplated by this Agreement, except for such authorizations,
consents, approvals or filings that, if not obtained or made, would
not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect on the Company.
(c) The execution and
delivery by the Company of this Agreement does not, and the
consummation of the transactions contemplated hereby and compliance
with the provisions hereof will not (i) result in any
violation of, or default (with or without notice or lapse of time,
or both) under, or give rise to a right of termination,
cancellation or acceleration of any obligation or to the loss,
alteration or impairment of a material benefit under any material
loan, guarantee of indebtedness or credit agreement, note, bond,
mortgage, indenture, lease, agreement, contract, instrument,
permit, concession, franchise, right or license binding upon the
Company or any of the Company’s Subsidiaries or result in the
creation of any Lien upon any of the properties or assets of the
Company or any of the Company’s Subsidiaries,
(ii) conflict with or result in any violation of any provision
of the certificate of incorporation or by-laws of the Company, as
amended (the “ Company Organizational Documents
”) or the certificate of incorporation or by-laws or other
equivalent organizational documents, in each case, as amended, of
any of the Company’s Subsidiaries, or (iii) conflict
with or violate any Laws applicable to the Company or any of the
Company’s Subsidiaries or any of their respective properties
or assets, other than, in the case of clauses (i) and (iii),
any such violation, conflict, default, right, loss or Lien that has
not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on the
Company.
Section 3.4 Reports and
Financial Statements .
(a) The Company has timely
filed or furnished all forms, statements, documents and reports
together with any amendments with respect thereto required to be
filed or furnished by it prior to the date hereof with the SEC
since July 1, 2006 (the “ Company SEC
Documents ”). As of their respective dates, or, if
amended, as of the date of the last such amendment, the
Company
24
SEC Documents complied in all material
respects, and all documents required to be filed by the Company
with the SEC after the date hereof and prior to the Effective Time
(the “ Subsequent Company SEC Documents ”) will
comply in all material respects, with the requirements of the
Securities Act, Exchange Act and the Sarbanes-Oxley Act (as defined
in Section 3.5), as the case may be, and the applicable rules
and regulations promulgated thereunder, and none of the Company SEC
Documents contained, and the Subsequent Company SEC Documents will
not contain, any untrue statement of a material fact or omitted, or
will omit, to state any material fact required to be stated therein
or necessary to make the statements therein, in light of the
circumstances under which they were made, or are to be made, not
misleading. As of the date hereof, there are no outstanding or
unresolved comments in comment letters received from the SEC with
respect to the Company SEC Documents. To the knowledge of the
Company, none of the Company reports is the subject of ongoing SEC
review. None of the Company Subsidiaries is required to file
reports with the SEC pursuant to the Exchange Act. As used herein
(except with respect to Section 3.8 and Section 4.8),
“knowledge,” with respect to the Company, shall mean
the actual knowledge of the persons listed in Section 3.4 of
the Company Disclosure Schedule, and with respect to Parent, shall
mean the actual knowledge of the persons listed in Section 4.4
of the Parent Disclosure Schedule.
(b) The consolidated
financial statements (including all related notes and schedules) of
the Company included in the Company SEC Documents fairly present in
all material respects, and included in the Subsequent Company SEC
Documents will fairly present in all material respects, the
consolidated financial position of the Company and its consolidated
Subsidiaries (for the avoidance of doubt, the representations in
this Section 3.4(b) shall not relate to the operations of the
Celera Group or the financial reporting thereof), as at the
respective dates thereof and the consolidated results of their
operations and their consolidated cash flows for the respective
periods then ended (subject, in the case of the unaudited
statements, to normal year-end audit adjustments and to any other
adjustments described therein including the notes thereto) in
conformity with United States generally accepted accounting
principles (“ GAAP “) (except, in the case of
the unaudited statements, as permitted by Form 10-Q of the SEC)
applied on a consistent basis during the periods involved (except
as may be indicated therein or in the notes thereto). Since
July 1, 2006, the Company has not made any material change in
the accounting practices or policies applied in the preparation of
its financial statements, except as required by GAAP, SEC rule or
policy or applicable Law.
Section 3.5
Sarbanes-Oxley Compliance . The Company is in compliance in
all material respects with all of the provisions of the
Sarbanes-Oxley Act of 2002 (“ Sarbanes-Oxley Act
”), and the provisions of the Exchange Act and the Securities
Act relating thereto which under the terms of such provisions
(including the dates by which such compliance is required) have
become applicable to the Company. Each of the principal executive
officer of the Company and the principal financial officer of the
Company (or each former principal executive officer of the Company
and each former principal financial officer of the Company, as
applicable) has made all certifications required by Rule 13a-14 or
15d-14 under the Exchange Act or Sections 302 and 906 of the
Sarbanes-Oxley Act and the rules and regulations of the SEC
promulgated thereunder with respect to the Company SEC Documents.
For purposes of the preceding sentence, “principal executive
officer” and “principal financial officer” shall
have the meanings given to such terms in the
25
Sarbanes-Oxley Act. Neither the Company
nor any of its Subsidiaries has outstanding, or has arranged any
outstanding, “ extensions of credit ” to
directors or executive officers within the meaning of
Section 402 of the Sarbanes-Oxley Act.
Section 3.6 No Undisclosed
Liabilities . Except (i) as reflected or reserved against
in the Company’s consolidated balance sheets (or as disclosed
in the notes thereto) included in the Company SEC Documents,
(ii) for liabilities and obligations incurred in the ordinary
course of business, consistent with past practice, since
June 30, 2007, (iii) liabilities or obligations which
have been discharged or paid in full in the ordinary course of
business and (iv) liabilities and obligations arising after
June 30, 2007, which, individually or in the aggregate, would
not reasonably be expected to have a Material Adverse Effect on the
Company, neither the Company, nor any Subsidiary of the Company
(including, for this purpose only, the entity listed in
Section 3.6 of the Company Disclosure Schedule, but only as to
the proportionate share of any liability or obligation of such
entity that is allocable to the Company), has any liabilities or
obligations of any nature, whether or not accrued, contingent or
otherwise, that would be required by GAAP to be reflected on a
consolidated balance sheet of the Company and its Subsidiaries (or
be required disclosure in the notes thereto).
Section 3.7 No Violation
of Law; Permits .
(a) The Company and each of
the Company’s Subsidiaries are in compliance with and are not
in default under or in violation of any federal, state, local or
foreign treaty, law, statute, ordinance, rule, regulation,
judgment, order, injunction, decree, arbitration award, agency
requirement, license or permit of any Governmental Entity
(collectively, “ Laws ”) applicable to the
Company, such Subsidiaries or any of their respective properties or
assets, including, without limitation, all authorizations under the
Federal Food, Drug and Cosmetic Act of 1938, as amended (the
“ FDCA ”), and the regulations of the U.S. Food
and Drug Administration (the “ FDA ”)
promulgated thereunder, and the Foreign Corrupt Practices Act of
1977, as amended, the Occupational Safety and Health Act, the Toxic
Substances Control Act, restrictions on technology transfer,
import, export and customs regulations, statutes and regulations
relating to government contracting, and Laws pertaining to privacy,
data protection, and the collection and use of personal
information, except where such non-compliance, default or violation
has not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on the
Company. Notwithstanding anything contained in this
Section 3.7(a), no representation or warranty shall be deemed
to be made in this Section 3.7(a) in respect of Sarbanes-Oxley
Act matters, environmental, employee benefits, tax, labor or
regulatory compliance matters, which are the subject of the
representations and warranties made in Sections 3.5, 3.8, 3.9,
3.15, 3.16 and 3.22 of this Agreement, respectively.
(b) The Company and the
Company’s Subsidiaries are in possession of all franchises,
grants, authorizations, licenses, permits, easements, variances,
exceptions, consents, certificates, approvals and orders of any
Governmental Entity required for the Company and the
Company’s Subsidiaries to own, lease and operate their
properties and assets or to carry on their businesses as they are
now being conducted (the “ Company Permits ”),
except where the failure to have any of the Company Permits has not
had, and would not reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect on the Company.
All
26
Company Permits are in full force and
effect, except where the failure to be in full force and effect has
not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on the
Company.
Section 3.8 Environmental
Laws and Regulations . (a) The Company and each of its
Subsidiaries are and, except with respect to matters that have been
fully and finally resolved, have been, since July 31, 2003, in
compliance with all applicable Laws relating to pollution or
protection of human health, the environment or natural resources
(including, without limitation, ambient air, surface water,
groundwater, land surface or subsurface strata) (collectively,
“ Environmental Laws ”), which compliance
includes, but is not limited to, the possession by the Company and
its Subsidiaries of all Company Permits that are required under
applicable Environmental Laws, and compliance with the terms and
conditions thereof, except for such non-compliance or failure to
possess such Company Permits as has not had, and would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect on the Company; (b) neither the
Company nor any of its Subsidiaries has received written notice of,
or is the subject of, any actions, causes of action, claims,
investigations, demands or notices by any person asserting an
obligation on the part of the Company or its Subsidiaries to
conduct investigations or clean-up activities under Environmental
Law, alleging non-compliance with any Environmental Law, or
alleging liability under any Environmental Law or under common law
with respect to matters relating to pollution or protection of
human health, the environment or natural resources, in each case,
which would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect on the Company (collectively,
“ Company Environmental Claims ”), and, to the
Company’s knowledge, there are no facts, circumstances or
conditions existing, initiated or occurring as of the date hereof
which provide a basis for Company Environmental Claims which have
had or would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect on the Company; and
(c) neither the Company nor any of its Subsidiaries has agreed
to assume the liability of any other person arising under
Environmental Law or under common law with respect to matters
relating to pollution or protection of human health, the
environment or natural resources which have had or would reasonably
be expected to have, individually or in the aggregate, a Material
Adverse Effect on the Company. As used in this Section 3.8 and
Section 4.8, “knowledge“ of any person means the
actual knowledge of the executive officers, of such person, which
shall include the principal executive, financial and operating
officers of each such person and the operating officer of each such
person with principal responsibility for compliance with
Environmental Law.
Section 3.9 Employee
Benefit Plans .
(a) Section 3.9(a) of
the Company Disclosure Schedule lists all material
(i) employee benefit plans, programs and policies (including,
for the avoidance of doubt, retirement benefit schemes) maintained
by, sponsored or participated in by the Company and its
Subsidiaries in which any current or former employees or directors
of the Company or its Subsidiaries participate, except to the
extent providing benefits imposed or implied by applicable foreign
Law (collectively, the “ Company Plans ”), and
(ii) contracts, offer letters and agreements of the Company or
its Subsidiaries with or addressed to any individual who is
rendering or has rendered services thereto as an employee or
consultant pursuant to which the Company or any of its Subsidiaries
has an obligation to provide compensation and/or benefits in
consideration for past, present, or future services (a “
Company Individual Agreement ”). The Company
Disclosure Schedule identifies each Plan that is intended to
be a “qualified plan” within the meaning of
Section 401(a) of the Code (“ Company Qualified
Plans ”).
27
(b) The Internal Revenue
Service has issued a favorable determination letter with respect to
each Company Qualified Plan and the related trust that has not been
revoked, and the Company knows of no existing circumstances that
would reasonably be expected to materially and adversely affect the
qualified status of any Company Qualified Plan or the related
trust.
(c) Except as would not have,
and would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect on the Company:
(i) all Company Plans are in compliance with and have been
administered in compliance with their governing provisions and all
applicable requirements of Law, including, but not limited to, the
Code and the Employee Retirement Income Security Act of 1974
(“ ERISA ”) as well as any similar
international, foreign, national, state or local Law; (ii) the
Company has not incurred any material liability under Title IV of
ERISA which has not been satisfied in full, and no event has
occurred and no condition exists that would reasonably be expected
to result in the Company incurring a material liability under Title
IV of ERISA; and (iii) none of the Company or its Subsidiaries
is required to contribute to, or during the six-year period ending
on the Closing will have been required to contribute to, any
“multiemployer plan” (as defined in
Section 4001(a)(3) of ERISA).
(d) With respect to each
Company Plan and Company Individual Agreement, the Company has
heretofore delivered or made available to Parent copies of each of
the following documents: (i) a copy of the Company Plan or
Company Individual Agreement or other governing documentation
(including amendments thereto); (ii) a copy of the most recent
Summary Plan Description (as defined in ERISA), if required under
ERISA; and (iii) with respect to each Company Qualified Plan,
a copy of the most recent determination letter received from the
Internal Revenue Service.
(e) The consummation of the
transactions contemplated by this Agreement will not, either alone
or in combination with another event, (A) entitle any employee
of the Company or any its Subsidiaries to severance pay or
compensation payments or any other benefits or rights, except as
expressly provided in this Agreement or as required by applicable
Law, or (B) accelerate the time of payment or vesting, or
increase the amount of compensation or benefits due any such
employee, except as expressly provided in this
Agreement.
(f) There is no contract,
agreement, plan or arrangement with any Company Employee to which
the Company or any of its Subsidiaries is a party as of the date of
this Agreement that, individually or collectively and as a result
of the transactions contemplated hereby (whether alone or upon the
occurrence of any additional or subsequent events) would reasonably
be expected to give rise to the payment of any amount that would
not be deductible pursuant to Sections 280G or 162(m) of the
Code.
28
(g) With respect to each
Company Plan that is not subject to United States Law (a “
Company Foreign Benefit Plan ”): (i) all employer
and employee contributions to each Company Foreign Benefit Plan
required by Law or by the terms of such Company Foreign Benefit
Plan have been made, or, if applicable, accrued in accordance with
GAAP, except for such contributions or accruals, the failure of
which to make or accrue has not had, and would not reasonably be
expected to have, individually or in the aggregate, a Material
Adverse Effect on the Company; and (ii) each Company Foreign
Benefit Plan required to be registered has been registered and has
been maintained in good standing with applicable regulatory
authorities, except for such failures to register or maintain as
have not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on the
Company.
Section 3.10 Absence
of Certain Changes or Events . From June 30, 2007, through
the date hereof, the Company and each of its Subsidiaries have
conducted their business in the ordinary course of such business
consistent with past practice, except as contemplated by this
Agreement in connection with the Merger and the transactions
contemplated thereby. From June 30, 2007, through the date
hereof, except as disclosed in the Company SEC Documents, neither
the Company nor any of its Subsidiaries has engaged in any
transaction or series of transactions material to the Company and
its Subsidiaries in the aggregate, other than in the ordinary
course of business consistent with past practice, and there have
not been (a) any Effects on or with respect to the Company
that constitute a Material Adverse Effect on the Company;
(b) any issuance by the Company, or agreement or commitment of
the Company to issue, any shares of capital stock or securities
convertible into or exercisable or exchangeable for, or that
evidence the right to subscribe for or acquire, shares of capital
stock, other than (i) grants of Company Stock Options,
Restricted Stock (and Stock Unit Awards issued in lieu of
Restricted Stock issued to directors who elect to defer stock
awards), Restricted Stock Unit Awards, Company Common Stock issued
to any director who elects to receive compensation in the form of
stock rather than cash (and Stock Unit Awards issued in lieu of
such Company Common Stock to any director who elects to defer
receipt of such Company Common Stock), or other equity grants for
compensatory purposes, and the grants of rights to acquire stock
under the ESPPs (including issuances of shares of Company Common
Stock pursuant to the ESPPs upon conversion of rights to purchase
Celera Group Common Stock into rights to purchase Company Common
Stock in connection with the Celera Separation) and
(ii) issuances of Shares upon exercise, vesting, or payout, as
applicable, of outstanding Stock Options, Restricted Stock Unit
Awards, Stock Unit Awards, and rights under the ESPPs; (c) any
repurchase, redemption or any other acquisition by the Company or
its Subsidiaries of any outstanding shares of capital stock or
other securities of, or other ownership interests in, the Company
or its Subsidiaries, other than pursuant to publicly disclosed
stock repurchase programs or as directed by a participant in any
Company Equity Plan, as permitted by the terms of such plan;
(d) any material change in accounting principles, practices or
methods, except as required by GAAP, SEC rule or policy or
applicable Law; and (e) any revaluation by the Company or any
of its Subsidiaries of any material amount of their assets, taken
as a whole, including, without limitation, write-downs of inventory
or write-offs of accounts receivable other than in the ordinary
course of business consistent with past practice or as required by
GAAP, SEC rule or policy or applicable Law.
29
Section 3.11
Investigations; Litigation . Except as described in the
Company SEC Documents:
(a) there is no investigation
or review pending (or, to the knowledge of the Company, threatened)
by any Governmental Entity with respect to the Company or any of
the Company’s Subsidiaries which has had, or would reasonably
be expected to have, individually or in the aggregate, a Material
Adverse Effect on the Company; and
(b) there are no actions,
suits, inquiries, investigations or proceedings (“
Claims ”) pending (or, to the knowledge of the
Company, threatened) against or affecting the Company, any of the
Company’s Subsidiaries or any of their respective properties
at law or in equity before, and there are no orders, judgments or
decrees of or before, any Governmental Entity, in each case, which
have had, or would reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect on the
Company.
Section 3.12
Information Supplied . None of the information supplied or
to be supplied by or on behalf of the Company for inclusion or
incorporation by reference in (i) the registration statement
on Form S-4 to be filed with the SEC by Parent in connection with
the issuance of Parent Common Stock in the Merger (including any
amendments or supplements, the “ Form S-4 ”)
will, at the time the Form S-4 becomes effective under the
Securities Act, contain any untrue statement of a material fact or
omit to state any material required to be stated therein or
necessary to make the statements therein not misleading or
(ii) the joint proxy statement/prospectus relating to the
Company Stockholders’ Meeting and the Parent
Stockholders’ Meeting, as amended or supplemented from time
to time and including all letters to stockholders, notices of
meeting and forms of proxies to be distributed to stockholders in
connection with the Merger, and any schedules required to be filed
with the SEC in connection therewith (the “ Joint Proxy
Statement ”), will, at the date it is first mailed to the
Company’s stockholders or at the time of the Company
Stockholders’ Meeting, contain any untrue statement of a
material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are made,
not misleading. The Joint Proxy Statement will comply as to form in
all material respects with the requirements of the Securities Act
and the Exchange Act and the rules and regulations thereunder.
Notwithstanding the foregoing provisions of this Section 3.12,
no representation or warranty is made by the Company with respect
to information or statements made or incorporated by reference in
the Form S-4 or the Joint Proxy Statement which were not supplied
by or on behalf of the Company.
Section 3.13 Rights
Agreement . The Company has taken all action so that the
execution of this Agreement, the consummation of the Merger and the
other transactions contemplated hereby do not and will not result
in the grant of any rights to any person under the Company Rights
Agreement or enable, require or cause the Company Rights to be
exercised, distributed or triggered thereunder.
Section 3.14 Lack of
Ownership of Parent Common Stock . Neither the Company nor any
of its Subsidiaries owns any shares of Parent Common Stock or other
securities convertible into shares of Parent Common Stock
(exclusive of any shares owned by the Company’s employee
benefit plans).
30
Section 3.15 Tax
Matters .
(a) The Company and each of
the Company’s Subsidiaries has (A) duly and timely filed
(or there has been filed on its behalf) all material Tax Returns
(as defined in Section 3.15(l)) required to be filed by it
(taking into account all applicable extensions) with the
appropriate Tax Authority (as defined in Section 3.15(l)), and
such Tax Returns are true, complete and accurate, and (B) paid
all Taxes shown as due on such Tax Returns, except for such
failures to file or pay which do not have, and would not reasonably
be expected to have, individually or in the aggregate, a Material
Adverse Effect on the Company.
(b) The most recent financial
statements contained in the Company SEC Documents filed prior to
the date of this Agreement reflect, in accordance with GAAP, an
adequate reserve for all Taxes payable by the Company and its
Subsidiaries for all taxable periods through the date of such
financial statements.
(c) Except for such Liens
which do not have, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on the
Company, there are no Liens for Taxes upon any property or assets
of the Company or any of the Company’s Subsidiaries, except
for liens for Taxes not yet due and payable or for which adequate
reserves have been provided in accordance with GAAP in the most
recent financial statements contained in the Company SEC Documents
filed prior to the date of this Agreement.
(d) There is no audit,
examination, deficiency, refund litigation or proposed adjustment
with respect to any Taxes other than those which do not have, and
would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect on the Company. As of the date
hereof, none of the Company or its Subsidiaries has received notice
in writing of any claim made by a Tax Authority in a jurisdiction
where the Company or any of its Subsidiaries, as applicable, does
not file a Tax Return, that the Company or such Subsidiary is or
may be subject to material taxation by that jurisdiction, where
such claim has not been resolved favorably to the Company or such
Subsidiary.
(e) There are no outstanding
written requests, agreements, consents or waivers to extend the
statutory period of limitations applicable to the assessment of any
Taxes or Tax deficiencies against the Company or any of the
Company’s Subsidiaries, except, in each case, with respect to
income Taxes or deficiencies, as the case may be, which do not
have, and would not reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect on the Company, and, as
of the date hereof, no power of attorney granted by either the
Company or any of its Subsidiaries with respect to any material
Taxes is currently in force.
(f) Neither the Company nor
any of its Subsidiaries is a party to any agreement providing for
the allocation, indemnification or sharing of Taxes other than such
an agreement exclusively between or among the Company and any
Company Subsidiary, other than Celera Corporation or the Celera
Group, and neither the Company nor any of its Subsidiaries (A)has
been a member of an affiliated group (or similar state, local or
foreign filing group) filing a material consolidated income Tax
Return (other
31
than a group the common parent of which
is the Company) or (B) has any material liability (including
as a result of any agreement or obligation to reimburse or
indemnify) for the Taxes of any other person (other than the
Company or any of its Subsidiaries) under Treasury Regulation
Section 1.1502-6 (or any similar provision of state, local or
foreign Tax Law), as a transferee or successor, by contract or
otherwise.
(g) Neither the Company nor
any of its Subsidiaries has: (A) agreed to make or is required
to make any adjustment for a taxable period ending after the
Effective Time under Section 481(a) of the Code by reason of a
change in accounting method or otherwise, except where such
adjustments do not have, and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect
on the Company; (B) constituted either a “distributing
corporation” or a “controlled corporation”
(within the meaning of Section 355(a)(1)(A) of the Code) in a
distribution of stock qualifying for tax-free treatment under
Section 355 of the Code (I) in the two years prior to the
date of this Agreement or (II) in a distribution which could
otherwise constitute part of a “plan” or “series
of related transactions” (within the meaning of
Section 355(e) of the Code) in connection with the Merger; or
(C) taken any action or knows of any fact, agreement, plan or
other circumstance that is reasonably likely to prevent the Merger
from qualifying as a “reorganization” within the
meaning of Section 368(a) of the Code.
(h) The Company and its
Subsidiaries will not be required to include any material item of
income in, or exclude any material item of deduction from, taxable
income for any taxable period (or portion thereof) ending after the
Effective Time as a result of any “closing agreement”
described in Section 7121 of the Code (or any corresponding or
similar provision of state, local or foreign income Tax Law)
executed on or prior to the date hereof, except for such inclusions
or exclusions which do not have, and would not reasonably be
expected to have, individually or in the aggregate, a Material
Adverse Effect on the Company.
(i) The Company and each of
its Subsidiaries is in material compliance with all applicable
information reporting and Tax withholding requirements under
federal, state and local Tax Laws, except for such failures to
comply which do not have, and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect
on the Company.
(j) Neither the Company nor
any of its Subsidiaries have been a party to or a participant in a
transaction which is listed, or otherwise reportable, within the
meaning of Section 6011 of the Code and Treasury Regulations
promulgated thereunder.
(k) Section 3.15(k) of
the Company Disclosure Schedule lists (i) all foreign
Subsidiaries of the Company for which material Tax Returns are
filed, and (ii) the jurisdictions in which the Company and
each of the Company’s Subsidiaries file a material Tax
Return.
(l) For purposes of this
Agreement: (i) “ Taxes ” means any and all
domestic or foreign, federal, state, local or other taxes of any
kind (together with any and all interest, penalties, additions to
tax and additional amounts imposed with respect thereto) imposed by
any Governmental Entity, including, without limitation, taxes on or
with respect to income, franchises, windfall or other
32
profits, gross receipts, property,
sales, use, capital stock, payroll, employment, unemployment,
social security, workers’ compensation or net worth, and
taxes in the nature of excise, withholding, ad valorem or value
added; (ii) “ Tax Authority ” means the
Internal Revenue Service and any other domestic or foreign
Governmental Entity responsible for the administration or
collection of any Taxes; and (iii) “ Tax Return
” means any return, report or similar filing (including the
attached schedules) required to be filed with respect to Taxes,
including, without limitation, any information return, claim for
refund, amended return, or declaration of estimated
Taxes.
Section 3.16 Labor
Matters . Except to the extent imposed or implied by applicable
foreign Law, as of the date hereof, neither the Company nor any of
its Subsidiaries is a party to, or bound by, any collective
bargaining agreement (or similar agreement or arrangement in any
foreign country) with employees, a labor union or labor
organization. Except for such matters which have not had, and would
not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect on the Company, (a) as of
the date hereof, (i) there are no strikes or lockouts with
respect to any employees of the Company or any of its Subsidiaries,
and, (ii) to the knowledge of the Company, there is no union
organizing effort pending or threatened against the Company or any
of its Subsidiaries; (b) there is no unfair labor practice,
labor dispute (other than routine individual grievances) or labor
arbitration proceeding pending or, to the knowledge of the Company,
threatened against the Company or any of its Subsidiaries, nor are
there any material industrial or trade disputes or negotiations
regarding a claim with any trade union, group or organization of
employees or their representatives representing employees or
workers; (c) there is no slowdown, or work stoppage in effect
or, to the knowledge of the Company, threatened with respect to any
employees of the Company or any of its Subsidiaries; and
(d) the Company and its Subsidiaries are in compliance with
all applicable Laws respecting (i) employment and employment
practices, (ii) terms and conditions of employment and wages
and hours, (iii) unfair labor practices, and (iv) the
Acquired Rights Directive and or any similar international,
foreign, national, state or local law, and any information and
consultation or similar obligation . Neither the Company nor any of
its Subsidiaries has any liabilities under the Worker Adjustment
and Retraining Notification Act of 1988, as amended (the “
WARN Act ”) or, to the knowledge of the Company, any
similar international, foreign, national, state or local law,
including without limitation the Acquired Rights Directive and
collective dismissal laws, as a result of any action taken or being
contemplated to be taken prior to the Effective Time by the Company
that have had, or would reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on the
Company. Except as has not had, and would not reasonably be
expected to have, individually or in the aggregate, a Material
Adverse Effect on the Company, neither the Company nor any of its
Subsidiaries has incurred any actual or contingent liability in
connection with any termination of employment of its employees
(including redundancy payments) or for failure to comply with any
order for the reinstatement or re-engagement of any employee and
neither the Company nor any of its Subsidiaries has incurred any
liability for failure to provide information or to consult with
employees under any employment Laws. Neither the Company nor any of
its Subsidiaries has established a European Works
Council.
33
Section 3.17
Intellectual Property .
(a) Section 3.17(a) of
the Company Disclosure Schedule sets forth, to the knowledge
of the Company, a true and substantially complete list of patents
and patent applications, trademarks (including common law marks,
registrations and applications), and Internet domain names, in each
case owned or co-owned by the Company or any of its Subsidiaries;
provided that Section 3.17(a) of the Company Disclosure
Schedule shall be deemed to include, with respect to the list of
Intellectual Property set forth therein, all of the following which
are owned or co-owned by the Company or any of its Subsidiaries:
(i) (a) any and all United States and foreign service
marks, logos, trade names, domain names, designs, slogans,
trademarks, trademark registrations and trademark applications
relating or corresponding to those listed in Section 3.17
(a) of the Company Disclosure Schedule, (b) any and all
United States and foreign common law rights relating to the
foregoing, and (c) any and all stylized and/or design mark
versions thereof; and (ii) (a) any and all parent,
continuation, continuation-in-part and/or divisional applications
relating or corresponding to those listed in Section 3.17
(a) of the Company Disclosure Schedule, (b) any and all
patents issuing thereon, (c) any and all reissues,
reexaminations or extensions of any of the foregoing, and
(d) any and all United States and foreign equivalents of the
foregoing.
(b) To the knowledge of the
Company: (1) all of the Intellectual Property which is listed
as active (e.g., not abandoned, inactive, lapsed, cancelled,
expired, and/or terminated) in Section 3.17(a) of the Company
Disclosure Schedule which is material to the Company or any of
its Subsidiaries taken as a whole (“ Material Intellectual
Property ”) is in full force and effect; (2) such
Intellectual Property has not been deemed by any Governmental
Entity to be invalid or unenforceable; (3) such Intellectual
Property has not been cancelled, abandoned or dedicated to the
public domain; and (4) all registration, maintenance and
renewal fees necessary to preserve the rights of the Company or its
Subsidiaries in connection with such Intellectual Property have
been paid in a timely manner.
(c) Except as would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect:
(i) the Company or a
Subsidiary of the Company owns, free and clear of any Liens (which,
for the avoidance of doubt, shall not be deemed to include license
agreements), or has a valid and enforceable license (free and clear
of any Liens) or otherwise possesses legally enforceable rights to
use and practice, all Intellectual Property as currently used in
their respective businesses as currently conducted;
(ii) to the knowledge of the
Company, the conduct of the businesses of the Company or its
Subsidiaries, as currently conducted, does not infringe upon or
otherwise violate any Intellectual Property of any third person;
neither the Company nor any of its Subsidiaries has received any
written notice since July 1, 2006 from any third person, and
there are no pending, or unresolved Claims (1) asserting the
infringement or other violation of any Intellectual Property by the
Company or any of its Subsidiaries or (2) pertaining to or
challenging the validity, enforceability, priority or
registrability of, or any right, title or interest of the Company
or any of its Subsidiaries with respect to, any Intellectual
Property;
34
(iii) neither the Company nor
any of its Subsidiaries has sent any written notice since
July 1, 2006, to any third person, and there are no pending or
unresolved Claims by the Company or any of its Subsidiaries
(1) asserting the infringement or other violation of any
Intellectual Property, or (2) pertaining to or challenging the
validity, enforceability, priority or registrability of, or any
right, title or interest of any third person’s Intellectual
Property;
(iv) there are no consents,
judgments, judicial or governmental orders, or settlement
agreements (including any settlements that include licenses)
restricting the rights of the Company or its Subsidiaries with
respect to any of the Intellectual Property owned or co-owned by
the Company or any of its Subsidiaries, or restricting the conduct
of any the businesses of the Company or any of its Subsidiaries as
presently conducted in order to accommodate a third person’s
Intellectual Property.
(d) Except as would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect, the Company and/or its Subsidiaries have
implemented commercially reasonable measures to maintain the
confidentiality of their trade secrets and other proprietary
information; and, to the knowledge of the Company, there has not
been any disclosure or other compromise of any confidential or
proprietary information of the Company or its Subsidiaries
(including any such information of any other person disclosed in
confidence to the Company or its Subsidiaries) to any third person
in a manner that has resulted or is likely to result in the loss of
trade secrets or other rights in and to such
information.
(e) For purposes of this
Agreement, the term “ Intellectual Property ”
means all intellectual property rights of any kind or nature,
including all United States, foreign and multinational
(i) trademarks, service marks, logos, trade names and
corporate names, Internet domain names, designs, slogans and
general intangibles of like nature, including, without limitation,
all goodwill, common law rights, registrations and applications
related to the foregoing, (ii) copyrights and mask works,
including, without limitation, all registrations and applications
related to the foregoing, (iii) patents, patent applications
and industrial designs (and the inventions embodied by the
foregoing), including, without limitation, all continuations,
divisionals, continuations-in-part, renewals, reissues,
re-examinations and applications related to the foregoing,
(iv) computer programs (whether in source code, object code,
or other form), algorithms, databases, compilations and data,
technology supporting the foregoing, and all documentation,
including user manuals and training materials, related to any of
the foregoing, and (v) trade secrets, technology, know-how,
proprietary processes, formulas, algorithms, models, methodologies
and other confidential information.
35
Section 3.18
Information Technology . Except as has not had, or would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect on the Company, (a) since July 1,
2006, (i) there have been, to the knowledge of the Company, no
security breaches in the Company’s or any of its
Subsidiaries’ information technology systems, and
(ii) there have been no disruptions in any of the
Company’s or its Subsidiaries’ information technology
systems that materially adversely affected the Company’s or
any of its Subsidiaries’ business or operations; and
(b) no material capital expenditures are necessary with
respect to the Company’s or its Subsidiaries’
information technology systems with respect to their businesses as
currently conducted, other than capital expenditures in the
ordinary course of business that are consistent with the past
practice of the Company or its Subsidiaries.
Section 3.19 Opinion
of Financial Advisor . The Board of Directors of the Company
has received the opinions of Morgan Stanley & Co.
Incorporated and Greenhill & Co., LLC, each dated the date
of this Agreement, substantially to the effect that, as of such
date, the Merger Consideration is fair to the holders of the
Company Common Stock from a financial point of view. The Company
will deliver a complete and accurate copy of such opinions to
Parent, which opinions shall be included in the Joint Proxy
Statement.
Section 3.20 Required
Vote of the Company Stockholders . The affirmative vote of
holders of a majority of the issued and outstanding shares of
Company Common Stock is the only vote of holders of securities of
the Company which is required to approve and adopt this Agreement
and the transactions contemplated hereby (the “ Company
Stockholder Approval ”).
Section 3.21 Material
Contracts .
(a) Except for this
Agreement, the Company Plans or as set forth in the Company SEC
Documents, as of the date hereof, neither the Company nor any of
its Subsidiaries is a party to or bound by any contract
constituting a “ material contract ” (as such
term is defined in Item 601(b)(10) of Regulation S-K of the
SEC) or (i) any other contract with the Company’s top
ten suppliers, customers, or sources of royalty revenue and expense
in fiscal year 2007; (ii) any contract creating or relating to
any material partnership, joint venture, alliance, or joint
development agreement; (iii) any contract (other than a
license agreement for Intellectual Property, to the extent that it
relates to the rights granted with respect to such Intellectual
Property) containing covenants binding upon the Company or any of
its Subsidiaries that materially restrict the ability of the
Company or any of its Subsidiaries (or that, following the
consummation of the Merger could materially restrict the ability of
the Surviving Company or its affiliates) to compete in any business
that is material to the Company and its affiliates, taken as a
whole, as of the date of this Agreement, or that restricts the
ability of the Company or any of its Subsidiaries (or that,
following the consummation of the Merger, would restrict the
ability of the Surviving Company or its affiliates) to compete with
any person or in any geographic area; or (iv) any contract
constituting a collective bargaining agreement (all contracts of
the type described in this Section 3.21 being referred to
herein as “ Company Material Contracts
”).
(b) Neither the Company nor
any Subsidiary of the Company is in breach of or default under the
terms of any Company Material Contract where such breach or default
has had, or would reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect on the Company. To the
knowledge of the Company, no other party to any Company
Material
36
Contract is in breach of or default
under the terms of any Company Material Contract where such breach
or default has had, or would reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on the
Company. Each Company Material Contract is a valid and binding
obligation of the Company or the Subsidiary of the Company which is
party thereto and, to the knowledge of the Company, of each other
party thereto, and is in full force and effect, except that
(i) such enforcement may be subject to applicable bankruptcy,
insolvency, reorganization, moratorium or other similar Laws, now
or hereafter in effect, relating to creditors’ rights
generally and (ii) equitable remedies of specific performance
and injunctive and other forms of equitable relief may be subject
to equitable defenses and to the discretion of the court before
which any proceeding therefor may be brought.
Section 3.22
Regulatory Compliance . Except as has not had, or would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect on the Company:
(a) all applicable operations
of the Company and each of its Subsidiaries have achieved and
maintained ISO 9001 certification, and there is no pending or, to
the Company’s knowledge, threatened, audit, repeal, failure
to renew or challenge to any such certifications; and
(b) to the Company’s
knowledge, each product distributed, sold or leased, or service
rendered, by the Company or any of its Subsidiaries complies with
all applicable product safety standards of each applicable product
safety agency, commission, board or other Governmental
Entity.
Section 3.23 Product
Recalls . Section 3.23 of the Company Disclosure
Schedule sets forth a list of (a) all recalls, field
notifications, field corrections and safety alerts with respect to
products manufactured and/or distributed by the Company or any of
its Subsidiaries, or by any person on behalf of the Company or any
of its Subsidiaries, in each case between July 1, 2006 and the
date of this Agreement, and the dates, if any, such recalls, field
notifications, field corrections and safety alerts were resolved or
closed, and (b) to the knowledge of the Company, any
complaints with respect to products produced by the Company or any
of its Subsidiaries, or by any person on behalf of the Company or
any of its Subsidiaries, that are open as of the date of this
Agreement, and that have had, or would reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect
on the Company. Except as has not had, or would not reasonably be
expected to have, individually or in the aggregate, a Material
Adverse Effect on the Company, there are no outstanding recalls,
field notifications, field corrections, safety alerts or product
complaints with respect to the products manufactured and/or
distributed by the Company or any of its Subsidiaries, or by any
person on behalf of the Company or any of its Subsidiaries, and, to
the Company’s knowledge, there are no facts that would be
reasonably likely to result in a material product recall, field
notification, field correction or safety alert with respect to any
such products.
Section 3.24
Affiliate Transactions . There are no Company Material
Contracts or other material transactions or agreements between the
Company or any of its Subsidiaries, on the one hand, and any
(a) officer or director of the Company or of any of its
Subsidiaries, (b) record or beneficial owner of five percent
or more of any class of the voting securities of the Company or
(c) affiliate of any such officer, director or beneficial
owner, on the other hand.
37
Section 3.25 Takeover
Provisions . The Board of Directors of the Company has adopted
a resolution or resolutions approving this Agreement, the Merger
and the other transactions contemplated hereby, and assuming the
accuracy of Parent’s representation and warranty contained in
Section 4.14, such approval constitutes approval of the Merger
and the other transactions contemplated hereby by the Board of
Directors of the Company under the provisions of Section 203
of the DGCL such that Section 203 of the DGCL does not apply
to this Agreement and the other transactions contemplated hereby.
To the knowledge of the Company, no state takeover statute other
than Section 203 of the DGCL (which has been rendered
inapplicable) is applicable to the Merger or the other transactions
contemplated hereby.
Section 3.26 Insurance
. The Company has previously made available to Parent all material
policies of insurance maintained by the Company or any of its
Subsidiaries as of the date hereof. Such policies are in full force
and effect and all premiums due with respect to such policies have
either been paid or adequate provisions for the payment by the
Company or one of its Subsidiaries thereof has been made, except
for such failures to be in full force and effect or to pay such
premiums as would not have a Material Adverse Effect on the
Company.
Section 3.27 Finders or
Brokers . Except for Morgan Stanley & Co. Incorporated
and Greenhill & Co., LLC, copies of whose engagement
agreements have been provided to Parent, neither the Company nor
any of its Subsidiaries has employed any investment banker, broker
or finder in connection with the transactions contemplated by this
Agreement who might be entitled to any fee or any commission in
connection with or upon consummation of the Merger.
Section 3.28 NO ADDITIONAL
WARRANTIES . EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES
EXPRESSLY SET FORTH IN THIS ARTICLE III, THE COMPANY AND ITS
SUBSIDIARIES HAVE NOT MADE AND DO NOT HEREBY MAKE ANY EXPRESS OR
IMPLIED REPRESENTATIONS AND WARRANTIES, STATUTORY OR OTHERWISE, OF
ANY NATURE, INCLUDING WITH RESPECT TO ANY EXPRESS OR IMPLIED
REPRESENTATION OR WARRANTY AS TO THE MERCHANTABILITY, QUALITY,
QUANTITY, SUITABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE OF THE
FACILITIES OR THE OTHER ASSETS OF THE COMPANY AND ITS SUBSIDIARIES.
EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES EXPRESSLY SET FORTH
IN THIS ARTICLE III, ALL OTHER WARRANTIES, EXPRESS OR IMPLIED,
STATUTORY OR OTHERWISE, OF ANY NATURE, INCLUDING WITH RESPECT TO
ANY EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY AS TO THE
MERCHANTABILITY, QUALITY, QUANTITY, SUITABILITY OR FITNESS FOR ANY
PARTICULAR PURPOSE OF THE FACILITIES OR THE OTHER ASSETS OF THE
COMPANY AND THE SUBSIDIARIES, ARE HEREBY DISCLAIMED BY THE COMPANY
AND ITS SUBSIDIARIES. It is understood that any cost estimate,
projection or other prediction, any data, any financial information
or presentations provided by the Company or any of its
representatives are not and shall not be deemed to be or to
include
38
representations or warranties of the
Company or its Subsidiaries. No person has been authorized by the
Company to make any representation or warranty relating to the
Company, its Subsidiaries, or the business of the Company or its
Subsidiaries or otherwise in connection with the transactions
contemplated hereby and, if made, such representation or warranty
may not be relied upon as having been authorized by the Company and
shall not be deemed to have been made by the Company.
ARTICLE IV
REPRESENTATIONS AND
WARRANTIES OF PARENT
Except as disclosed in the
Parent SEC Documents (excluding any disclosures set forth in any
section of a filed Parent SEC Document entitled “Risk
Factors” or “Forward-Looking Statements” or any
other disclosures included in such filings to the extent that they
are forward-looking in nature) or in the corresponding section of
the Disclosure Schedule delivered by Parent to the Company
immediately prior to the execution of this Agreement (the “
Parent Disclosure Schedule ”) (it being agreed that
(x) disclosure of any item in any section of the Parent
Disclosure Schedule shall be deemed disclosure with respect to
any other section of this Agreement to which the relevance of such
item is reasonably apparent from the face of such disclosure and
(y) no reference to or disclosure of any item or other matter
in the Parent Disclosure Schedule shall be construed as an
admission or indication that (1) such item or other matter is
material, (2) such item or other matter is required to be
referred to or disclosed in the Parent Disclosure Schedule or
(3) any breach or violation of applicable Laws or any
contract, agreement, arrangement or understanding to which the
Parent is a party exists or has actually occurred), Parent and
Merger Sub represent and warrant to the Company as
follows:
Section 4.1
Qualification; Organization, Etc.
(a) Parent is a corporation
duly organized, validly existing and in good standing under the
Laws of the State of Delaware and has the corporate power and
authority to own its properties and assets and to carry on its
business as it is now being conducted. Parent is duly qualified or
licensed to do business and is in good standing in each
jurisdiction in which the ownership of its properties or the
conduct of its business requires such qualification, except for
jurisdictions in which the failure to be so qualified or in good
standing has not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on
Parent. The copies of Parent’s certificate of incorporation
and by-laws which have been delivered to the Company are complete
and correct copies thereof, each as amended through the date
hereof. Parent is not in violation of any provision of its
certificate of incorporation or by-laws.
(b) Section 4.1(b) of
the Parent Disclosure Schedule sets forth a list of each
Subsidiary of Parent that, as of the date of this Agreement, is a
significant subsidiary (as defined in Rule 1-02 of Regulation S-X
of the SEC) (collectively, the “ Parent Significant
Subsidiaries ”). Except as set forth in
Section 4.1(b) of the Parent Disclosure Schedule, all the
outstanding shares of capital stock of, or other equity interests
in, each Parent Significant Subsidiary have been validly issued and
are fully paid and nonassessable and are owned directly or
indirectly by Parent, free and clear of all Liens and free of any
other restriction (including preemptive rights
39
and any restriction on the right to
vote, sell or otherwise dispose of such capital stock or other
ownership interests). Merger Sub and each of the Parent Significant
Subsidiaries is a corporation, partnership or other entity duly
organized, validly existing and, if applicable, in good standing
under the Laws of its jurisdiction of incorporation or
organization, has the power and authority to own its properties and
to carry on its business as it is now being conducted, and is duly
qualified or licensed to do business and, if applicable, is in good
standing in each jurisdiction in which the ownership of its
property or the conduct of its business requires such
qualification, except for jurisdictions in which the failure to be
so qualified or in good standing has not had, and would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect on Parent.
Section 4.2 Capital
Stock .
(a) As of June 5, 2008,
the authorized capital stock of Parent consists of 200,000,000
shares of common stock, par value $.01 per share (“ Parent
Common Stock ”), 2,202,942 shares designated as Series A
convertible redeemable preferred stock, par value $.01 per share
(“ Convertible Preferred Stock ”), 2,202,942
shares designated as redeemable preferred stock, par value $.01 per
share (“ Redeemable Preferred Stock ”), and
1,000,000 shares designated as Series B preferred stock, par value
$.001 per share, reserved for issuance pursuant to the Rights
Agreement (the “ Parent Rights Agreement ”),
dated February 27, 2001, between Parent and Fleet National
Bank (the “ Series B Preferred Stock ,” and,
together with Convertible Preferred Stock and Redeemable Preferred
Stock, “ Parent Preferred Stock ”). As of
June 5, 2008, (i) 92,154,372 shares of Parent Common
Stock were outstanding and (ii) no shares of Parent Preferred
Stock were outstanding. As of June 5, 2008, the following
numbers of shares of Parent Common Stock were subject to
outstanding grants under the Parent Equity Plans (as defined in
this Section 4.2(a)): (1) 9,495,154 shares of Parent
Common Stock were issuable upon the exercise or settlement of
options under the Invitrogen Corporation 2004 Equity Incentive Plan
(the “ Parent 2004 Plan ”) and 1,541,768 shares
of Parent Common Stock were issuable upon the exercise or
settlement of restricted stock units under the Parent 2004 Plan,
(2) 2,117,878 shares of Parent Common Stock were issuable upon
the exercise or settlement of options under the Invitrogen
Corporation 1997 Stock Option Plan (the “ Parent 1997
Plan ”), (3) 32,066 shares of Parent Common Stock
were issuable upon the exercise or settlement of options under the
Invitrogen Corporation 2001 Stock Incentive Plan (the “
Parent 2001 Plan ”), (4) 28,152 shares of Parent
Common Stock were issuable upon the exercise or settlement of
options under the Invitrogen Corporation 2002 Stock Incentive Plan
(the “ Parent 2002 Plan ”), (5) 3,000
shares of Parent Common Stock were issuable upon the exercise or
settlement of options under the Life Technologies 1997 Long Term
Incentive Plan (the “ Parent 1997 LTIP ”), and
(6) 20 shares of Parent Common Stock were issuable upon the
exercise or settlement of options under the Invitrogen Corporation
2000 Non-Statutory Stock Option Plan (the “ Parent 2000
Plan ”), and, together with the Parent 2004 Plan, Parent
1997 Plan, Parent 2001 Plan, Parent 2002 Plan and Parent 1997 LTIP,
the “ Parent Equity Plans ”). As of June 5,
2008, 507,352 shares of Parent Common Stock were subject to
outstanding option grants outside the Parent Equity Plans. As of
June 5, 2008, 10,258,290 shares were issuable upon the
conversion of Parent’s 3 1 / 4 % Convertible
Senior Notes due 2025 (the “ 3 1 / 4 %
Notes ” ) , 8,821,350 shares were issuable upon
the conversion of Parent’s 1 1 / 2 % Convertible
Senior Notes due 2024 (the “ 1 1 / 2 %
Notes ”),
and 7,124,600 shares were
40
issuable upon conversion of
Parent’s 2% Convertible Senior Notes due 2023 (the “
2% Notes ”). As of June 5, 2008
(a) 3,299,979 shares of Parent Common Stock were reserved for
issuance under the Parent 2004 Plan, (b) 2,117,878 shares of
Parent Common Stock were reserved for issuance under the Parent
1997 Plan, (c) 32,066 shares of Parent Common Stock were
reserved for issuance under the Parent 2001 Plan, (d) 28,152
shares of Parent Common Stock were reserved for issuance under the
Parent 2002 Plan, (e) 3,000 shares of Parent Common Stock were
reserved for issuance under the Parent 1997 LTIP, and (f) 20
shares of Parent Common Stock were reserved for issuance under the
Parent 2000 Plan. All of the outstanding shares of Parent Common
Stock and Parent Preferred Stock are, and all shares of Parent
Common Stock which may be issued, including shares of Parent Common
Stock which may be issued pursuant to this Agreement, shall be,
when issued in accordance with the respective terms thereof, duly
authorized, validly issued and are fully paid and non-assessable
and free of preemptive rights.
(b) Except as set forth in
subsection (a) above, as of the date hereof, (i) Parent
does not have any shares of its capital stock issued or outstanding
other than shares of Parent Common Stock that were issued after
June 5, 2008, but were reserved for issuance as set forth in
subsection (a) above, and (ii) there are no outstanding
subscriptions, options, warrants, calls, convertible securities, or
other similar rights, agreements or commitments relating to the
issuance of capital stock to which Parent or any of its
Subsidiaries is a party obligating Parent or any Subsidiary of
Parent to, in either case, (A) issue, transfer or sell any
shares of capital stock or other equity interests of Pa
|